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ABSTRACT
The innate immune system requires input from a myriad of tissues and cell types
to adequately prepare, locate, and neutralize infections. Skeletal muscle’s widespread
distribution throughout the body and its potent ability to secrete cytokines makes it a vital
signaling organ to alert the immune system during both localized and systemic injuries
and illnesses. This dissertation first deciphers the crosstalk between skeletal muscle
myocytes and macrophages during acute lung injury, reporting the macrophage-derived
cytokine, tumor necrosis factor α, to be necessary for eliciting the full potential of the
skeletal muscle inflammatory milieu. Next, the total contribution of skeletal muscle
mediators is quantified using muscle specific knockouts for toll-like receptor 4,
interleukin-6, and C-C motif chemokine ligand 2. These novel mouse strains allow for
targeted ablation of the receptor and effector molecules involved in endotoxemia
specifically in myocytes, providing insight on the proportion of inflammatory cytokines
derived from these muscle cells. Finally, to improve skeletal muscle and exercise
research, a novel, open-source mouse exercise wheel is presented that allows for
controllable and trackable experimentation. This device improves upon existing methods
by allowing researchers to limit animals based on time- and distance- milestones.
Together, these data provide a comprehensive examination spanning from molecular
signaling to animal modeling of the mechanisms and magnitude to which skeletal muscle
regulates immune homeostasis.
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW
1.1 Introduction
In 2016, we set out to determine how skeletal muscle contributes to lung injury
and if exercise could ameliorate the pathology to improve outcomes. In the process, we
investigated the cellular interactions between muscle and leukocytes, the overall systemic
cytokine burden of muscle, and improved upon existing models of murine exercise. The
following dissertation will describe the following aims:
Aim 1: Understand muscle’s response to lung injury and its modulation of
inflammation (Chapter 2).
Aim 2: Quantify the contribution of muscle to the systemic inflammatory
response (Chapter 3).
Aim 3: Design and execute an improved tool for murine exercise (Chapter 4).
The subsequent dissertation chapters are written in the form of journal articles,
each with their own introduction containing detailed information tailored to the
experiments that follow. Therefore, this introduction is designed to highlight some of the
interesting and important aspects of muscle-immune crosstalk, inflammation, and
exercise modeling that are not covered in the body of this dissertation.
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1.2 Overview of resident cells within skeletal muscle
Interlaced between the multinucleated myofibers of skeletal muscle lie a
heterogenous population of unique cell types, all specialized to the muscle
microenvironment. Single cell sequencing1 and single nuclei sequencing2 have revealed
that these cell types differ over muscle development and muscle fiber type. From
leukocytes to fibroblasts, the overarching categories of resident cells are depicted in
Figure 1.

Figure 1 Resident cells of skeletal muscle. Skeletal muscle function depends on more
than the multinucleated myofibers that occupy the bulk of the organ. Constant use and
damage require a host of mononuclear resident cells to maintain the tissue
microenvironment. The muscle must also be supplied with a constant source of oxygen
through the vasculature endothelial cells that support movement controlled by motor
neurons. Intermingled leukocytes provide guidance to rebuild after injury as well as to
protect against infection.
2

The following sections highlight a few important cell types within muscle,
particularly macrophages and satellite cells. Together, these two cell types orchestrate a
precise dance of inflammation and growth to repair skeletal muscle and prevent fibrosis
and their crosstalk is vital to proper skeletal muscle homeostasis. These sections will also
introduce coculture techniques used in Chapter 2 of this dissertation and, in preparation
for Chapter 3, the importance of muscle derived cytokines.

1.3 Satellite cells
In his 1961 publication, Alexander Mauro described and named satellite cells due
to their location between the plasma and basement membranes of myofibers3. When
observed under a light microscope they were “indistinguishable from a peripheral nucleus
proper,” but through an electron microscope the plasma membrane of the myofiber and
satellite cell could be identified as separate entities4. The intimate nature of these cells
with muscle fibers provided the framework of how muscle repopulates its nuclear
stockpile during growth and injury.
Muscle fibers contain hundreds of nuclei, each contributing their own influence
on cellular events. However, the reach of these nuclei are constrained to myonuclear
domains5. Therefore, development of muscle requires either the division of nuclei within
the fiber, or addition of new nuclei4. During normal muscle growth, the latter is required
and fulfilled by satellite cells. During steady-state conditions, these cells are quiescent. A
combination of Wnt6, transforming growth factor β (TGFβ)7, and fibroblast growth factor
(FGF)8 signaling leads to the activation of the transcription factor paired box 7 (PAX7),
causing satellite cells to begin to proliferation and differentiation into myogenic
precursors and finally into myofibers.
3

Whereas cellular fusion is required for the development of muscle tissue, it is not
necessary for strength. McCarthy and colleagues created a satellite cell ablation mouse
using a CRE-estrogen receptor fusion protein driven by a Pax7 promoter9. This mouse
was crossed with a Rosa26 mouse containing a diphtheria toxin gene that was held
inactive by a floxxed stop cassette. Tamoxifen injections yielded a 90% reduction in
satellite cells. In their experiments, mice were subjected to synergistic ablation, a model
of hypertrophy in which the gastrocnemius and soleus muscles are removed, resulting in
a doubling of the plantaris muscle size10. After 2 and 6 weeks, muscle strength and crosssectional area were assessed – shockingly, there were no differences in muscle strength or
size between knockout and control groups. However, in line with the paradigm, control
mice sustained myonuclear increases while this aspect was blunted in the knockout mice.
Additionally, the control mice were able to produce de novo fibers that were absent in the
mice lacking satellite cells9.
During these periods of skeletal muscle proliferation, differentiation, and fusion,
there is a delicate balance of pro- and anti- inflammatory responses that dictate the fate of
satellite cells and their progeny. A lack of inflammation leads to impaired muscle
regeneration, while prolonged anti-inflammatory and growth signals result in collagen
rich, fibrotic tissue. At the intersection of satellite cells, fibro-adipogenic precursors, and
myofiber regeneration lies the macrophage, a sentinel leukocyte, and the orchestrator of
injury resolution.

1.4 Macrophages
The macrophage is a versatile cell type that finds its home in nearly every tissue.
This resident leukocyte is embryonically derived as well as self-renewing during steady
4

state conditions11. Early hematopoiesis occurs in the yolk sack and fetal liver, where
macrophage precursors develop then migrate to nascent tissues11. Muscle macrophages
can also be repopulated by circulating monocytes to maintain their numbers12. The
primary role of these cells is to be constantly surveying their surroundings and inspecting
their environment for pathogens and damage. As such, macrophages are a critical cell
type for proper tissue/muscle homeostasis.
To execute these critical functions, macrophages utilize their pattern recognition
receptors (PRRs). This class of receptors contains several families, the toll-like receptors
(TLRs), the nucleotide-binding oligomerization domain-like-like receptors (NLRs), the
retinoic acid-inducible gene 1-like receptors (RLRs), and the C-type lectin receptors
(CLRs). Collectively, they recognize pathogen or damage associated molecular patterns
(PAMPs, DAMPs). These receptors were predicted by Charles Janeway in 198913, but it
was not until 1997 when mammalian TLR4 was formally identified by his postdoctoral
fellow, Ruslan Medzhitov14. The primary ligand of TLR4 is lipopolysaccharide (LPS), a
component of Gram-negative bacterial membranes. TLR4 has also been reported to
recognize several putative DAMPs including high mobility group box 1 (HMGB1)15 and
heat shock proteins (HSP)16, although the latter is subject to controversy in literature17 as
well as in our own laboratory. When TLR4 is stimulated, two signal transduction
pathways are activated. The adaptor proteins myeloid differentiation primary response 88
(MyD88) and TIR-domain-containing adapter-inducing interferon-β (TRIF) associate
with the intracellular domain of TLR4 and induce an inflammatory response through
activation of the transcription factors nuclear factor kappa B (NF-κB) and interferon
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regulatory factor 3 (IRF3), respectively. The nuclear localization of these transcription
factors ‘activates’ the macrophage and begins the polarization to an inflammatory state18.
The classifications of M1 and M2 polarized macrophages are misleading as these
phenotypes often overlap and are not as exclusive as the names suggest (think shades of
grey rather than black and white). For the context of this dissertation, the prototypical
macrophage phenotypes are described. When a PRR is stimulated, the cell begins to
polarize toward an M1 (classically activated) state19. Its role is two-fold, the macrophage
must first work to kill and phagocytose pathogens and debris whilst signaling to other
innate leukocytes that there is an infection or tissue damage. To call out for help, cells
that have been stimulated with PAMPs and DAMPs secrete cytokines – these small
proteins potently travel through the microenvironment and to the vasculature, creating a
gradient to guide circulating leukocytes to the injury and infection20. In this context,
cytokines can also inform cells the types of infection, the extent of which to respond, and
which cells are needed. Macrophages signal to the cells of the microenvironment, often
using tumor necrosis factor α (TNFα)21, as we report in Chapter 2 of this dissertation.
This potent pro-inflammatory cytokine has been recorded as a key messenger for
macrophages crosstalk with the gut22, bone23, adipose tissue24, and liver25. As an infection
or injury resolves, the macrophage can transition toward an M2 (alternatively activated)
phenotype. This phenotype is guided by the cytokines interleukin-4 (IL-4), IL-10, and the
process of efferocytosis19. The alternatively activated macrophage now has a new
function – promotion of wound healing and cellular growth to achieve tissue
homeostasis. Characteristics and markers of macrophage subsets are outlined in Figure 2.
While two macrophage polarization states have been described here, the continuum is
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multi-faceted, and often there are phenotypes that lie outside of this classification
system26. The plasticity and intricacies of polarization allow macrophages to be both
soldiers against damage as well as architects to repair and remodel tissue. Both roles are
prominently on display in muscle where the precise coordination is required.

Figure 2 Macrophage polarization phenotypes. M0 macrophages are polarized to an
M1 phenotype using LPS, IFNγ, or GM-CSF in both in vitro and in vivo settings. M2
polarization can occur through combinations of IL-4, IL-10, or IL-13 to drive different
M2 subsets. Alternatively, macrophages can acquire an M2 phenotype when they
phagocytose dead and dying cells in a process called efferocytosis. Polarized
macrophages can be identified using surface markers for each state, secreted products, or
through gene expression of iNos (formally named Nos2), Fizz1, and Arg1. Gene
expression data from bone marrow derived macrophages that have been treated with
IFNγ (20 ng/ml) or IL-10 (20 ng/ml) for 24 hours show a distinct pattern of M1 and M2
phenotypes.

7

1.5 Myogenic coordination between macrophages and skeletal muscle
The reasonable assumption can be made that throughout an individual’s life, the
majority of macrophage and muscle interactions will be in the context of normal tissue
homeostasis and in some instances due to injury, rather than critical illness. However, in
cases of sepsis and endotoxemia-like critical illness, macrophage-muscle crosstalk could
be vital to systemic inflammatory signaling, as is described through the work in the next
chapter. Following muscle injury, whether it be a tear, pull, or crush, there is a sequence
of events that need to be executed to regenerate muscle: proliferation of myogenic
precursors, differentiation into myocytes, and fusion into myofibers. The interplay
between muscle and macrophages is detailed below and in Figure 3.

8
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Immediately following injury, satellite cells need to awake from their quiescent
state and begin to proliferate. These cells are held in their torpor by the Notch family of
signaling proteins, which control their self-renewal and restrict premature differentiation
and loss of their stem-cell characteristics27, 28, 29. Cytokines are involved early in the
process – TNFα and IL-1β induce the expression of retinoid orphan receptor tyrosine
kinases, driving Wnt signaling that antagonizes Notch pathways and induces proliferation
and differentiation of satellite cells30, 31. During the proliferative step of repair, myofibers
and satellite cells secrete C-C motif chemokine ligand 2 (CCL2), to attract macrophages
from the vasculature and gather resident macrophages already present in the muscle.
These M1 skewed macrophages hurry to the tissue where they clear debris to make room
for the new myofibers32. CCL2 secretion peaks three days after injury when macrophages
have accumulated in the damaged tissue.
To find damaged and dying cells, macrophages probe the area for “eat me”
signals, which are molecules that become exposed to the cell surface during apoptosis.
Phosphatidylserine (PS) is ubiquitous throughout tissues as an eat me signal for
phagocytosing macrophages33, 34.
As a short aside and relevant to the 2021 Nobel Prize in Physiology or Medicine,
PS is also involved in myogenesis through Piezo1 sensing. When PS is exposed to
the outer membrane, Piezo1 activity decreases and subsequent actomyosin
complexes cannot form. Disruption of the flippases that control PS leaflet
distribution leads to unpolarized myotubes and aberrant fusion to adjacent
myotubes. Whereas normal myotubes are elongated straight structures, myotubes
deficient in this process appear star-like35. While macrophages have not been
10

directly implicated in the clean-up of PS rich myofibers, there appears to be a
parallel between normal efferocytotic behavior and need to clear PS rich cells for
proper myogenesis.
The process of efferocytosis turns the M1 macrophages toward their M2, antiinflammatory phenotypes and also forces the macrophages to begin secretion of TGF-β
which promotes injury resolution and directs satellite cells away from prolifation36.
It is important to retain a pool of satellite cells for subsequent injuries. After the
proliferative phase is initiated, some cells continue to exist as satellite cells, while others
turn into myoblasts that terminally differentiate through upregulation of the transcription
factor myoblast determination protein 1 (MyoD). A potential mechanism determining cell
fate can be attributed to asymmetrical division of satellite cells. During proliferation, the
mitotic spindle is perpendicular to the myofiber, creating an apical-basal division. The
basal daughter cell closest to the fiber retains its satellite cell phenotype, while the apical
daughter continues onward to repair injury37. The apical MyoD+ myoblasts proliferate
further, elongate, and fuse together to form nascent myofibers with the help of the
transcription factors myogenic factor 5 (Myf5), myogenic regulatory factor (Mrf4), and
myogenin38, 39, 40. Macrophages that have begun their switch to M2 secrete TGF-β, which
enhances the maturation of myoblasts36. Myoblasts will continue migrate toward and to
fuse to the growing myofibers until the muscle is repaired41.
To further highlight the importance of macrophage-muscle crosstalk, we can
briefly examine the effects when macrophages are removed from or overrepresented in
the regenerative process. In mice treated with chlodronate liposomes to deplete
macrophages, muscle is unable to fully recover from injury as shown by decreased
11

myofiber size, increased pro-inflammatory cytokines, and excessive fibrosis42, 43.
Additionally, in macrophage depleted models, debris is not removed, and muscle
regeneration is essentially halted 36. In scenarios of constant chronic inflammation such
as Duchenne muscular dystrophy, regenerative signaling elicited by macrophages runs
awry. The constant inflammation accumulates M1 and M2 macrophages into muscle,
where M1 macrophages signal for proliferation; meanwhile, M2 macrophages force
satellite cells into fibrotic machines that, with the help of fibro-adipogenic precursors,
turn the muscle into a poorly contractile, collagen-laden tissue44. Chronic inflammation
appears to be required for overstimulation of macrophages and extracellular matrix
accumulation, as acute M1 macrophage injections into laceration injuries promotes
healing and reduces fibrosis45. The finely tuned system of pro-inflammatory mediated
proliferation followed by anti-inflammatory signaled differentiation and resolution relies
heavily on macrophage interactions with satellite cell and myoblasts. These principles
merit the use of coculture systems to model interactions between the cells in contexts
outside of injury resolution.

1.6 C2C12 myotubes
To understand the intrinsic ability of a cell to respond to external stimuli, there are
often too many variables to use an in vivo model. In the case of skeletal muscle, to
determine the ability of myofibers to respond to LPS induced injury, we would need to
remove every contaminating cell type in Figure 1. Therefore, the work in Chapter 2 relies
heavily on the C2C12 myotubes model. This reductionist strategy allows us to build a
model then add the significant cell types back in to assess their individual and
synergistic/antagonistic contributions.
12

C2C12 cells are a subcultured iteration of an immortal myogenic precursor
created by Yaffe and Saxel in 197746. The original C2 cells were obtained 70 hours after
a crush injury in C3H mice and were selected for indefinite proliferation and maintained
ability to form multinucleated, contractile myotubes. These rapidly diving cells more
closely resemble myoblasts than satellite cells, as they have reduced PAX7 activity47.
Their differentiation from myoblast to myotube is initiated by reducing fetal bovine
serum concentrations from 10% to 1- 2%. Over 7 days, this starvation influences the
myoblasts to fuse together and begin to form the machinery required for skeletal muscle
contraction48.
The timing of C2C12 differentiation is an integral part of the in vitro muscle
model. Many groups use their myotubes 3-4 days following differentiation49, 50. At this
point, the cells may be multinucleated, but they do not terminally differentiate and form
the bulk of actin/myosin complexes until days 6 and 748. In atrophy-based models, this
means that researchers are often studying growth inhibition, rather than catabolism51.
Because of this varied methodology, our studies contrast previous literature that have
found that bacterial lipopolysaccharide causes atrophy in C2C12 myotubes49. Upon 24hour stimulation with LPS, we found no evidence of atrophy, as assessed through
measurements of myotube diameter and gene expression of muscle RING-finger protein1 (MuRF1), a muscle specific ubiquitin ligase that aids in the autophagy of myosin heavy
chain (Figure 4).
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Figure 4
A

B

Figure 4 LPS does not induce
myotube atrophy. C2C12
myotubes treated with 1 ug/ml of
LPS after 7-day differentiation
protocol. A) Cross sectional
measurements of myotube
diameter. B) Expression of the
muscle specific ubiquitin ligase,
MuRF1.
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To represent uninjured, fully formed muscle, we terminally differentiated the
myotubes for experiments in Chapter 2. Once our C2C12 model was established, we
began to add another cell type to the system, the bone marrow derived macrophage
(BMDM).

1.7 Bone marrow derived macrophages
Early in the work of this dissertation, a choice was made about which macrophage
to use in coculture experiments: would it be appropriate to use a macrophage-like cell
line such as J774 or Raw264.7? Alternatively, should a primary cell be used instead of an
immortalized counterpart? For the latter option, which tissue should be used for
macrophage isolation? J774 cells have been successfully used in culture with C2C12
myotubes52, are readily available, and easy to work with. However, our enthusiasm for
this approach was limited by the fact that these cells will continue to proliferate
exponentially within the coculture system and would not be representative of the numbers
within healthy skeletal muscle. Conversely, bone marrow derived macrophages
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(BMDMs) are terminally differentiated and have a limited capacity to divide53, 54.
Additionally, these cells could be taken from mice of diverse genetic backgrounds, such
as the TLR4-/- mice that were used in our study55. Using in vitro differentiated cells also
decreases heterogenicity, as macrophage populations specialize to each organ and display
unique characteristics across tissues56. For example, macrophages isolated from spleens
have the ability to recycle iron and scavenge erythrocytes57, alveolar macrophages are
well suited for clearing inhaled pathogens and surfactant within the lung, and microglia
can influence synaptic development58. In the end, the choice was made to incorporate
BMDMs into the coculture system. As an alternative, thioglycolate-elicited peritoneal
macrophages were also considered. However, BMDMs outperform peritoneal
macrophages in phagocytic capacity, plasticity, and cytokine release59. Consequently,
BMDMs, in conjugation with our C2C12 myotubes, would form the coculture model
used in our research.

1.8 In vitro muscle coculture systems
Coculture systems allow researchers to determine if multiple cell types interact
with one another during a treatment regimen. C2C12 myotubes are no strangers to other
cells within their wells. Systems have been set up with PC12 and NG108-15 cells60, 61, 62,
3T3 fibroblasts63, and a myriad of adipocyte combinations64, Appendix A. These
microphysiological systems are often used to assess differentiation, proliferation, or
contractile ability of myotubes. In hand with these studies, macrophages have been
shown to be a pivotal part of muscle formation. This is prominently on display in work
conducted by Juhas and colleagues in 2018, in which they combined bone marrow
derived macrophages with murine satellite cells to create myotube constructs that were
15

then implanted into the panniculus carnosus muscle of mice. Constructs containing
macrophages underwent angiogenesis within 15 days, whereas constructs lacking
macrophages remained isolated from the vasculature65.
Coculture systems are often performed in 2D, but with the recent advances in
organoid development and muscle systems have advanced into the third dimension with
their coculture partners. These 3D coculture systems come closer to physiologically
modeling the microenvironment and have successfully innervated myotubes66, created
bone-muscle junctions67, and generated double-organoid systems to model cancer
cachexia68. While these new methods approach physiological settings, reductionist
models cannot fully recapitulate in vivo settings. For that, there is a need to use murine
models, as performed in Chapter 3.

1.9 Skeletal muscle drives systemic change in vivo
The reductionist strategy of cell culture models can help explain basic interactions
between cells and ligands, or a collection of cell types in a certain environment, but to
study the outcomes of a disease, or to model a systemic inflammatory event (Chapters 2
and 3), animal models need to be utilized. The global distribution and intense
vascularization of skeletal muscle facilitates communication to local or distal organ
systems. For example, an injury to muscle increases the pain mediator prostaglandin E2
while also secreting cytokines to sensitize local dorsal root ganglion69. These same
cytokines enter circulation to attract leukocytes to the injury. The final physiological
response is unwillingness to use the injured muscle thus allowing time for recovery.
Interventions in this process cannot be tested using cell monolayers, cocultures, or even
organoids, and thus animal models are needed.
16

The crosstalk between muscle and distal organs is best studied in the context of
exercise. Cytokines secreted during and following muscle contraction (myokines) instruct
the rest of the organism to prepare for a decrease in available energy, and that a
reparative process may be required. IL-6 was the first myokine to be discovered and
increases 100-fold after an acute exercise bout70. Muscle derived IL-6 functions
differently following exercise than in inflammatory settings. During an infection it
activates the Jak-Stat pathway to propagate immune activation and direct adhesion of
leukocytes71, 72. Following exercise, IL-6 signals to adipocytes to liberate free fatty acids
and causes the liver to increase gluconeogenesis. IL-6 also autocrine signals to increase
glucose uptake73.
The effects of exercise can also have a positive impact on lung injury. Files and
colleagues showed that forced exercise after intratracheal LPS administration dampened
neutrophilic lung injury. This decrease was found to be due to an exercise induced
reduction of granulocyte colony stimulating factor (G-CSF). The reduction of circulating
G-CSF was also seen in patients with respiratory failure undergoing early mobility
therapy compared to controls who received no exercise74. Connecting muscle and
exercise to lung injury lead to one of the essential questions of this dissertation: what is
the contribution of muscle to the inflammatory cytokine profile?

1.10 Cytokines
The language of the immune system contains hundreds of cytokines, receptors,
and soluble mediators. To add complexity the cytokine dictionary, many are pleiotropic
or redundant (homonyms and synonyms, to continue the language metaphor). IL-6 has
already been addressed, but to further illustrate the point, IL-2 also has interesting duality
17

to both induce and reduce the adaptive immune response. After naïve T cells are
activated by antigen presenting cells, they begin to produce IL-2 and autocrine signal to
proliferate and differentiate into effector (Teff) and memory cells. Teff create a positive
feedback loop by secreting IL-2 to expand in quantity, but as the immune response begins
to subside these cells are no longer needed75. Regulatory T cells (Treg) reduce the Teff
response and by competing with Teff for the IL-2. Since Treg cannot produce IL-276, they
express a greater quantity of IL-2 receptor to outcompete the Teff77. Treg then decrease Teff
numbers by a combination of IL-10, IL-35, and TGFβ signaling as well as cytotoxic
mediation78. In this scenario, IL-2 would be the word “braces” that align teeth in the
United States but hold up a pair of pants in the United Kingdom. Despite speaking the
same language, T cells can have different responses to the same cytokine.
In order to have day-to-day conversations in a new language, the speaker must
know about 800-2,000 commonly used words out of 170,00079. Likewise, to understand
this dissertation, the knowledge of only a handful of the roughly 150 cytokines and
chemokines is sufficient. The subsequent chapters have a narrow focus around TNFα, IL6, CCL2, and C-X-C motif chemokine ligand 1 (CXCL1). These four cytokines represent
major groups of inflammatory initiation, systemic inflammation, macrophage
recruitment, and neutrophil recruitment. The vocabulary is relatively useless without
correct sentence structure; therefore, the temporal expression of these cytokines and their
definitions are detailed in Figure 5.
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Figure 5 Featured cytokines and their kinetics. A) In experimental lung injury,
sepsis, and critical illness, cytokines follow a similar temporal trend. Following
initiation of illness, TNFα (and IL-1β) begin the pro-inflammatory response. At
the site of injury, these cytokines potentiate IL-6 production that induces the
systemic acute phase response driven by the liver. The chemokines CXCL1 and
CCL2 are next to be induced. The expression of these chemokines extends longer
than and IL-6. B) In single bolus LPS injections, all four cytokines are rapidly
induced. The kinetics of this model may not accurately represent the disease
phenotype, but prove useful in mechanistic studies (discussed in Chapter 3). C-F)
Common cytokines, structures, and their involvement in inflammation. Figure
complied using80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91. Research Collaboratory for
Structural Bioinformatics Protein Data Bank accession numbers: 1TNF, 1IL6,
1IL8, 1DOM.

Briefly, these cytokines can induce different types of tissue damage, either
directly or indirectly through leukocytic activities. As mentioned earlier, TNFα is an
important signaling molecule for macrophages and monocytes, but can also induce
cellular apoptosis through intrinsic92 and extrinsic93 pathways. On the level of tissue
damage, TNFα promotes vascular permeability to create swelling. Controlled tight
junction relaxation allows for easier extravasation by circulating leukocytes94, but
unregulated TNFα signaling leads to hypotension95 and excessive edema96, 97. Once
TNFα induced inflammation has begun, IL-6 promotes the acute phase response by the
liver. This response rapidly adds serum amyloid proteins, C-reactive proteins, and
complement proteins to circulation and induces fever98, 99. Prolonged activity of IL-6
propagates inflammation and contributes to the pathogenesis of rheumatoid arthritis100.
The chemokines CCL2 and CXCL1 attract monocytes/macrophages and
neutrophils, respectively. While the signaling from these molecules alone does not induce
tissue damage, the resulting leukocytes can devastate organs. As neutrophils leave the
circulation, they secrete neutrophil elastase to clear their path through the tissue as they
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follow the chemotactic gradient to the source of CXCL1101. This serine protease causes
collateral damage to the cells in their path102. Once neutrophils and macrophages find
pathogens, they secrete nitric oxide and reactive oxygen species to eliminate
infections103. Like TNFα, when these processes are regulated, inflammation can be
resolved, and cells can be repaired. However, dysregulated leukocyte activity in the lung
pushes acute lung injuries and infections into acute respiratory distress syndrome and
breakdown of the organ104.
To mitigate uncontrolled inflammation, anti-inflammatory cytokines are
upregulated when the immune response is no longer needed. In systemic illness, IL-10
and IL-1 receptor agonist (IL-1ra) can be induced concurrently with TNFα and IL-683,
but their effects are not seen until after the initial inflammatory cytokine wave. IL-10
signaling can downregulate the four previously mentioned cytokines, but can also be
dysregulated itself. Overproduction of anti-inflammatory cytokines can terminate the
immune response prematurely and keep it suppressed105. In turn, pathogens can
reestablish their infections and further harm or even kill the host. These complex
interactions of pro- and anti-inflammatory cytokines require the use of animal models, as
we see in Chapter 3.

1.11 Muscle specific conditional knockouts
Several conditional knockout mice strains were created to understand the
contribution of muscle derived cytokines to systemic inflammation. Each of the TLR4,
IL-6, and CCL2 knockouts use a modified estrogen receptor (MER)-Cre recombinaseMER fusion protein construct (MerCreMer). This technology was originally developed
by Littlewood and colleagues containing only a single MER domain at the C-terminus106.
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This chimeric transgene can be driven by a ubiquitous or tissue specific promoters and is
constitutively expressed and translated, but initially does not bind DNA. Instead, it is
sequestered in the cytoplasm by HSP90107 and remains inactive until bound by
tamoxifen. Shortly after the introduction of CreMer, a second construct was generated in
which a MER was introduced to the N-terminus108. This construct showed enhanced
inactivation in the absence of tamoxifen and better recombination when the drug was
added109.
The MerCreMer construct was introduced into skeletal muscle under a human
skeletal actin promoter (HSA-MCM) in 2012110. We utilized this mouse to employ a
receptor and effector scheme for our knockouts. By knocking out TLR4 specifically in
skeletal myocytes, we anticipated that there would be measurable changes in the
cytokines generated downstream of LPS-induced TLR4 activation. For a more specific
approach, we also used IL-6 and CCL2 muscle specific knockouts. These effectors would
allow us to measure individual proteins that originated from muscle. These strains may
not have been possible without the NIH Policy on Sharing Model Organisms111, which
complements our values in Chapter 4 to create a free and open-source mouse wheel to
enable investigators to freely use our improved and affordable design for their studies.

1.12 Open-source labware
The penultimate chapter of this dissertation was inspired by a need to improve
existing methods of exercise modeling, a limited budget (Appendix B), and reluctance to
enrich laboratory equipment companies that over-price their goods (Figure 6). What
originally began as a New Year’s resolution to learn a coding language turned into the
Lockable Open-Source Training-Wheel (LOST-Wheel) and a desire to add to the open
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labware community that aims to decrease scientific costs112, 113. The trend of increasing
prices of laboratory equipment was acknowledged by Eve Marder in 2013. She notes that
state of the art discoveries often require the latest, greatest, and most expensive
equipment reserved for well-funded institutions114. These discoveries appear to feed back
into the inequality amongst NIH funded researchers. Recent data show that labs in the top
10% of funding receive 45% of research project grants (RPG), and the top 1% receive
10% of RPGs115. While these laboratories undoubtedly produce great science, it forces
less funded and early career researchers to be creative in their methodologies and
equipment costs.
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Figure 6 Commercial and 3D
printed labware. A broad range of
labware can be made (left column)
for a fraction of the cost of
commercially available products
(right column). 3D print price is
based on 15% infill, 0.28 mm layer
height, and $20/kg filament. A) 4way tube rack116, 117 B) Pipette
stands118, 119 C) Mini centrifuge116,
117
D) Syringe pump and 3x syringe
pump with microscope120, 121.
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Perhaps these exercises in ingenuity provided some beneficial results, as
creativity was on display at the beginning the COVID-19 pandemic. Researchers
designed and implemented ventilators122, valves122, and air purification devices123 to stop
the spread of the SARS-CoV-2. Open-source COVID-19 devices were uploaded to the
National Institute of Health’s 3D print exchange to be curated by experts, and shared
freely across the globe124. To meet the need for testing, labs turned to Open PCR to
handle their thermocycling and fluorescent reads125. As supply caught up with demand,
these devices were phased out, but the ability to rapidly prototype, test, and freely
distribute code and hardware was vital early on. As we look to a time-after-COVID,
vaccinations will need to be freely distributed across the world. While some companies
chose to protect their profits and patents, other scientists have taken the open-source
mindset to create an inexpensive and globally scalable recombinant protein vaccine126, 127.
While it is unlikely that the LOST-Wheel will save a patient’s life, and its price is
a drop in the bucket compared to the latest Illumina sequencer, it highlights that scientific
equipment can be produced for a fraction of the cost and made freely available to
scientists. Equitable access to such valuable equipment by less-privileged investigators
demands that open-source sharing should be encouraged.

1.13 Summary
The previous sections highlight methods, concepts, and processes that are not
covered within the remaining text of this dissertation. Chapters 2, 3, and 4 will expand
upon these sections, with experimental evidence of TNFα crosstalk between macrophages
and muscle, the contribution of muscle to the inflammatory environment, and a novel
mouse wheel for improved voluntary exercise, respectively.
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Abstract
Muscle may contribute to the systemic inflammatory environment during critical
illness, but leukocyte interaction and cytokine influence on muscle and its response has
not been fully explored in this context. Using an in vivo model of intratracheal
lipopolysaccharide (IT LPS) induced acute lung injury, we show that skeletal muscle
rapidly responds with expression of pro-inflammatory genes, which may be explained by
migration of LPS into the circulation. Treatment of mature C2C12 myotubes with LPS at
a level achieved in the circulation following IT LPS elicited a proinflammatory cytokine
expression profile similar to that of in vivo murine muscle following IT LPS. Stimulation
with toll like receptor (TLR) 2 and 3 agonists provoked comparable responses in C2C12
myotubes. Additionally, co-cultures of C2C12 myotubes and bone marrow derived
macrophages (BMDM) identified the capacity of macrophages to increase myotube
proinflammatory gene expression, with tumor necrosis factor-α (TNFα) gene and protein
expression largely attributable to BMDM. To investigate the contribution of TNFα in the
synergy of the co-culture environment, C2C12 myotubes were treated with recombinant
TNFα, co-cultures were established using TNF-deficient BMDMs, and co-cultures were
also depleted of TNFα using antibodies. To determine if the in vitro observations were
relevant in vivo, mice received intramuscular administration of LPS ± TNFα or TNFαneutralizing antibodies and showed that TNFα is both sufficient and necessary to induce
synergistic cytokine release from muscle. Taken together, these data demonstrate how
skeletal muscle tissue may contribute proinflammatory cytokines following acute
endotoxin injury and the potential of leukocytes to augment this response via TNFα
secretion.
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Introduction
Acute respiratory distress syndrome (ARDS) affects nearly 200,000 people per
year in the United States (1, 2). The majority of ARDS survivors develop long-term
sequelae, including physical, cognitive, and mental health impairments that may persist
for the rest of their lives (3). Up to 60% of patients with ARDS experience skeletal
muscle atrophy and weakness, termed intensive care unit acquired weakness (ICUAW)
(4). Patients with ICUAW have more ventilator days, greater mortality, and are much less
likely to return to their pre-illness level of health (5-7). Serial muscle biopsies taken from
patients in the ICU and confirmed with ultrasonography and biochemical measurements,
showed that muscle wasting was greater in those with multiorgan failure (8). While
muscle atrophy can be a result of critical illness, it may also be an underappreciated
effector of outcomes and the local and systemic inflammatory milieu in critical illness.
Skeletal muscle produces pro-inflammatory cytokines following ICU admission (9), and
studies in mice report robust nuclear factor-κB (NF-κB) activation followed by cytokine
upregulation in skeletal muscle in models of ARDS (10). Because muscle composes up to
40% of body mass, and contains up to 75% of the body’s protein, the role of muscle as a
contributor to systemic inflammatory tone in critical illness may be substantial (11).
Studies in healthy individuals, mice, and in vitro culture systems show that
muscle secretes many inflammatory cytokines and broadly affects systemic cytokine
levels (12, 13), with interleukin-6 (IL-6) being the prototypical muscle derived cytokine
that has systemic effects on lipid and glucose metabolism (14). Pro-inflammatory
cytokines elicit a reparative process within the tissue in response to muscle
contraction/injury consisting of coordinated recruitment of myeloid cells, particularly

38

neutrophils and macrophages (15), where these cells play a vital function of
phagocytosing debris, stimulating resident muscle stem cell (satellite cell) proliferation,
and remodeling the extracellular matrix (16). Alteration of macrophage populations leads
to delayed muscle healing and fibrosis (16). Many of the cytokines involved in this
process are also present in the muscle of critically ill patients; particularly macrophage
chemoattractant protein-1 (CCL2, MCP-1), tumor necrosis factor-α (TNFα), and
interleukin-8 (IL-8, murine homolog chemokine (C-X-C motif) ligand 1, CXCL1, KC)
(9). In critical illness, macrophages accumulate in the muscle of patients with ICUAW (8,
17), yet how these cells interact with skeletal muscle tissue and their contribution to local
and systemic inflammation is unknown.
Given that muscle can respond rapidly to mechanical and inflammatory stimuli by
producing mediators that are apparent in the circulation with critical illness and that
macrophages are known to augment muscle injury/repair, we hypothesized that muscle
tissue upregulates several pro-inflammatory cytokines early after lung injury and that this
cytokine profile can be amplified by macrophage-derived TNFα. We used a model of
murine ARDS involving intratracheal (IT) lipopolysaccharide (LPS) administration to
determine the temporal response of muscle to lung injury. Because of the heterogeneity
of cell types within muscle, we utilized C2C12 myotube cultures to discern the
contribution of muscle and other cell types to the cytokine/chemokine response to LPS.
The results of these combined in vivo and in vitro studies suggest myocytes as a potential
source of systemic inflammatory cytokine release in critical illness and implicate muscleassociated or infiltrating leukocytes as contributing substantially to muscle’s response to

39

LPS-induced lung injury, as well as the necessity and sufficiency of TNFα in this
response.

40

Methods
Mice – 12-20-week-old male C57BL6/J mice (The Jackson Laboratory) were
housed in the AALAC-accredited animal facilities at the University of Vermont, and all
experimental animal procedures were approved by the University of Vermont
Institutional Animal Care and Use Committee. Mice were maintained on 12-hour
light/dark cycle and were provided chow (~15% kcal from fat; TestDiet, St. Louis, MO)
and water ad libitum.
Intratracheal (IT) LPS - Escherichia coli LPS (O55:B5, MilliporeSigma St.
Louis, MO, USA) was instilled according to mouse weight at a concentration of 3 μg/g,
as described by Files et al. (18). Briefly, mice were anesthetized using ketamine (135
mg/kg, Vedco, Inc., St. Louis, MO, USA) and xylazine (1 mg/kg, Akorn, Inc., Lake
Forest, IL, USA) to achieve a surgical plane of anesthesia. A small incision was made in
the skin above the trachea to visualize intubation. A 20-gauge catheter (Smiths Medical,
Minneapolis, MN, USA) was inserted into the trachea and LPS or saline was then
administered using a pipette and gel-loading tips. The mice were then placed on a
mechanical ventilator (Harvard Apparatus, Holliston, MA, USA) for 30 seconds (280 μL
tidal volume, 160 breaths/min). Mice were then extubated, and the incision was closed
using VetBond (3M, Saint Paul, MN, USA). Animals recovered under a warming light
before being returned to their cages.
Mice were euthanized at 3, 6, 12, 24, or 72h after LPS or saline instillation by
pentobarbital (Vortech Pharmaceuticals, Dearborn, MI, USA) overdose and
exsanguination. Plasma, bronchioalveolar lavage (BAL) fluid, and gastrocnemius muscle
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of these mice were collected. Samples were snap frozen in liquid nitrogen and BAL cells
were scored for total and differential cell counts.
FITC-labeled LPS (E. coli 055:B5 FITC-LPS, MilliporeSigma) was administered
intratracheally at a concentration of 3 μg/g, as described above. Mice were euthanized at
2h. Cardiac punctures were used to collect terminal blood samples. Serum was isolated
using MiniCollect Tubes (Greiner Bio-one, Kremünster, Austria). A standard curve was
created using FITC-LPS in rat serum (Stemcell Technologies, Vancouver, Canada).
Fluorescence intensity was measured at 485/20 nm excitation, 528/20 nm emission, on a
Synergy HTX plate reader and Gen5 software (BioTek, Winooski, VT, USA).
Intramuscular (IM) injections – C57BL6/J mice were anesthetized using
isoflurane and the lower hindlimb shaved. Injections of saline, Escherichia coli LPS
(O55:B5, 10 ng/mouse), anti-TNFα antibody (10 μg/mouse, Bio X Cell, Lebanon, NH),
anti-horseradish peroxidase (10 μg/mouse, isotype control, Bio X Cell), TNFα (50
ng/mouse), or combinations of LPS/antibody or LPS/TNFα were administered in 25 μl of
volume directly into the gastrocnemius muscle. The mice were allowed to recover from
anesthesia and were euthanized 3 hours later. Gastrocnemius was removed and analyzed
for gene expression.
Cell Culture - C2C12 myoblasts (CRL1772; American Type Culture Collection,
Manassas, VA, USA) were passaged in growth media (GM) consisting of low glucose (1
g/L) Dulbecco’s Modified Eagle Media (DMEM) supplemented with 10% fetal bovine
serum (FBS) and 1% penicillin and streptomycin (GIBCO, Thermo Fisher Scientific,
Waltham, MA). All experiments were carried out using cells before the 9th passage. Cells
were seeded at a density of 3.5x104 cells/well on 24 well plates (CELLTREAT Scientific
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Products, Pepperell, MA, USA) that were previously coated with Matrigel (Corning,
Bedford, MA, USA) at a concentration of 60 μg/cm2 -(19). Cells were allowed to grow to
~90% confluency at which point GM was removed and differentiation media (DM)
containing high glucose (4.5 g/L) DMEM, 2% FBS, and 1% penicillin/streptomycin
(GIBCO). DM was changed daily, and cells were differentiated for 7 days before
treatments of Ultrapure LPS (1 μg/mL, Invivogen, San Diego, CA, USA), Pam3CSK4 (1
μg/mL, Invivogen), or Poly(I:C) (50 μg/mL, MilliporeSigma) At this time, C2C12
myotubes have myosin content required for contraction, indicating complete
differentiation (19).
BMDM were generated from C57BL/6J, B6;129S-Tnftm1Gkl (TNFα-/-), or
B6129SF2/J (TNFα+/+) mice (The Jackson Laboratory, Bar Harbor, ME, USA) using a
protocol described by Raza et al. (20). Briefly, mice were anesthetized with isoflurane
and euthanized by cervical dislocation. Femurs and tibias were dissected and placed in
phosphate buffered saline (PBS, GIBCO) on ice. The ends of the bones were removed
and flushed with PBS to remove whole marrow. Cells were mechanically dissociated
using a pipette and washed by centrifugation. Marrow was then resuspended in
macrophage differentiation media containing high glucose (4.5 g/L) DMEM, 10% FBS,
1% P/S, 1% L-Glutamine (GIBCO), and 10 ng/ml macrophage colony stimulation factor
(PeproTech, Rocky Hill, NJ, USA). Cells were plated onto Petri dishes in 10 mL media and
allowed to differentiate for 7 days with the addition of 5 mL of macrophage
differentiation medium on day 3.
Co-cultures were created by staggering the differentiation of BMDM and C2C12
myotubes. BMDM were isolated and began differentiation one day before C2C12
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myotubes. On the seventh day of BMDM differentiation, plates were washed using PBS
and non-adherent cells were removed. BMDM were detached from the Petri dish using
Trypsin (GIBCO), washed, and resuspended in 1 mL of macrophage differentiation
medium for counting. 4940 BMDM/well (26 cells/mm2) were plated onto the C2C12
myotubes during their daily media change and incubated overnight. This cell quantity
was derived from a published report (21) and is extrapolated from an in vivo model of
disuse myopathy (21, 22). Additionally, histological analysis of uninjured skeletal muscle
ranges from 4-75 macrophages/mm2 (21, 23). Several reports using flow cytometry
report lower ratios of macrophages relative to myocytes present in the skeletal muscle
(24, 25), yet conversions to a cell culture monolayer or histology sections make it
difficult to compare values. BMDM were seeded onto C2C12 myotubes during the 6th
day of differentiation. After BMDM adhered and acclimated to the reduced serum of the
differentiation media overnight, the co-cultures were stimulated with LPS (1 μg/mL,
Invivogen) or in combination with anti-TNFα antibody (10 μg/mL, eBioscience, San
Diego, CA, USA) or Anti-Horseradish Peroxidase antibody as an isotype control (10
μg/mL, Bio X Cell, Lebanon, NH, USA).
RNA isolation and quantitative real-time polymerase chain reaction (qRT-PCR) - Total
RNA was isolated from C2C12 cells and whole muscle using TRIzol reagent followed by
a chloroform-isopropanol extraction (Thermo Fisher Scientific). The concentration and
quality were measured using a NanoDrop 2000 spectrophotometer (Thermo Fisher
Scientific). cDNA was synthesized from 100 ng of RNA using the qScript Supermix
reagent kit per manufacturer’s instructions (Quantabio, Beverly, MA, USA). Quantitative
real-time PCR was performed using iTaq Universal SYBR Green Supermix on a CFX96
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Touch (Bio-Rad, Hercules, CA, USA), with the relative mRNA expression calculated
using the threshold cycle (Ct; 2-ΔΔCt) method normalized to Gapdh expression. The
following primer sequences are in 5’ to 3’ format. Il6 forward
CCCGGAGAGGAGACTTCACAG, reverse GAGCATTGGAAATTGGGGTA; Ccl2
forward GCTGGAGAGCTACAAGAGGAT, reverse
ACAGACCTCTCTCTTGAGCTTGGT; Cxcl1 forward
GCTGGGATTCACCTCAAGAA reverse TGGGGACACCTTTTAGCATC; Tnf forward
TCCCAGGTTCTCTTCAAGGGA reverse GGTGAGGAGCACGTAGTCGG; Tnf
(Figure 3, mapped to deleted exon) forward CCACCACGCTCTTCTGTCTA reverse
ACTGATGAGAGGGAGGCCAT; Gapdh forward ACGACCCCTTCATTGACCTC
reverse TTCACACCCATCACAAACAT; Tlr4 forward
AAATGCACTGAGCTTTAGTGGT reverse TGGCACTCATAATGATGGCAC; Cd68
forward GACCGCTTATAGCCCAAGGA reverse TCATCGTGAAGGATGGCAGG;
Lysm forward GAACGTTGTGAGTTTGCCAGA reverse
GAGCTAAACACACCCAGTCG.
Protein quantification by enzyme-linked immunosorbent assays (ELISAs) and
Luminex multiplex – Levels of IL-6, CCL2, CXCL1, and TNFα were quantified using
DuoSet ELISA kits according to the manufacturer’s protocol (R&D Systems,
Minneapolis, MN, USA). Absorbance was read at 570 nm and background was removed
using 450 nm absorbance on a Synergy HTX plate reader and Gen5 software (BioTek).
For measurements on gastrocnemius muscle, tissue (>100 mg) was placed within
gentleMACS M Tubes (Miltenyi Biotec, Waltham, MA) containing 500 μL PBS and
protease inhibitor cocktail (MilliporeSigma) and lysed on a gentleMACS Dissociator
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according to manufacturer’s settings. Lysate was then passed through QIAshredder spin
columns (Qiagen, Germantown, MD, USA). Total supernatant protein content was
measured using a Micro BCA Protein Assay Kit (Thermo Fisher Scientific). In some
experiments, plasma and cell culture supernatants were analyzed by a custom Luminexbased multiplex assays (R&D Systems) for mouse IL-6, TNFα, CCL2, CXCL1, and IL1β, according to manufacturer instructions. In some instances, data were extrapolated
beyond the upper and lower limits of quantitation by the BioPlex Manager Software
(Bio-Rad) and used for graphical presentation and statistical analyses.
Statistics – Data were analyzed using Graphpad Prism 8 (Graphpad Software, San
Diego, CA, USA). Data are presented as means ± SEM. Data from each experiment were
confirmed at least one replication. Experimental groups were compared using one- and
two-way ANOVA with appropriate post-hoc tests, as indicated in figure legends.
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Results
Muscle responds rapidly to LPS induced lung injury and to in vitro LPS
To establish acute lung injury, a single bolus of LPS (3 μg/g) or an equivalent
amount of saline was administered IT to C57BL/6J mice that were euthanized at 3, 6, 12,
24, and 72 hours later. Bronchoalveolar lavages (BAL) were performed to assess airspace
inflammatory cell accumulation (Figure 1 A). Leukocytes increased between the 6h and
12h timepoint, with a slight, but sustained increase to ~6x106 cells from 24 to 72 hours.
The infiltrating population consisted mostly of neutrophils (Figure 1 B) while
macrophages remained unchanged (Figure 1 C). Plasma from the 3h time point was
analyzed for circulating cytokines (Figure 1 E-H) and showed significant LPS-induced
increases in IL-6, CCL2, CXCL1, and TNFα. Moreover, gastrocnemius muscle
interleukin 6 expression (Il6, IL-6) as well as expression and translation of both
macrophage chemoattractant protein 1 (Ccl2, CCL2) and chemokine (C-X-C motif)
ligand 1 (Cxcl1, CXCL1) were rapidly and significantly increased, with peak expression
at 3h post-injury (Figure 1 I-K). Tumor necrosis factor-α (Tnf) was elevated compared to
saline controls, reaching statistical significance at 6 hours only (Figure 1 L). Macrophage
infiltration was assessed by RT-qPCR for cluster of differentiation 68 (Cd68) and
lysozyme 2 (Lysm), which showed no changes and implicate that only resident muscle
macrophages were present at this timepoint within the gastrocnemius muscle (data not
shown). At three hours, gastrocnemius muscle from LPS treated mice showed
significantly elevated CCL2 protein compared to saline controls (Figure 1 N, O). CXCL1
was also increased (p=0.0595), but IL-6 and TNFα showed no difference between muscle
from LPS or saline treated mice (Figure 1 M, P). To discern the potential mediator of
47

these systemic and muscle tissue responses, we evaluated the possibility that IT LPS was
present in the systemic circulation. Using FITC-labeled LPS, at 2h we found a significant
increase in serum LPS (Figure 1 D), indicating that approximately 2% of the initial
amount administered IT was present in the systemic circulation. We attribute the
fluorescence (and therefore a reported quantity of LPS) present in the saline control
group to a species difference in autofluorescence in the FITC channel between the serum
used to generate the standard curve (rat) and that of the samples (mouse), not to the
presence of circulating LPS.
To determine whether muscle cells are capable of pro-inflammatory cytokine
production similar to that observed in vivo and to explore the effects of various TLR
ligands, we used an in vitro C2C12 myotube model treated with LPS (1 μg/mL), toll like
receptor 2 (TLR2) agonist Pam3CSK4 (1 μg/mL), or TLR3 agonist poly(I:C) (50 μg/mL)
and quantified mRNA expression at 0, 2, 4, 8, and 24 hours following exposure (Figure
2). All three stimuli induced significant increases in gene expression of Il6, Ccl2, and
Cxcl1 at 2h compared to untreated controls (Figure 2 A-C). Ccl2 and Cxcl1 expression
declined at the 4h time point, whereas Il6 was upregulated in experimental treatments
through 24h. Tnf was modestly, but significantly increased at 2h in the LPS group only
(Figure 2 D). Protein secretion in the supernatant was measured at 24h and IL-6, CCL2
and CXCL1 were significantly higher than control following stimulation with TLR
ligands (Figure 2 E-G, p<0.0001), however TNFα was not detected (Figure 2 H).
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Figure 1. Intratracheal LPS elicits systemic and muscle specific responses preceding
cellular infiltration of the airspace. A) Total cells returned from the airspaces following
four, 800 μl instillations of 0.1% BSA in PBS. B and C) Neutrophil and macrophage
quantification in bronchoalveolar lavage fluid following differential scoring. Ordinary 2way ANOVA with Sidak multiple comparisons. Stars indicate differences between
treatments at a given timepoint. *** p<0.001, **** p<0.0001. n=3-9 per treatment per
timepoint. D) LPS concentration in serum 2 hours following LPS-induced acute lung
injury (I.T. LPS 3 μg/g). Unpaired t test. ****p<0.0001. n=5-6 per group. E-H) Plasma
cytokine concentration 3 hours following LPS-induced acute lung injury. Unpaired t test
from log10-transformed concentrations. **p<0.01, ***p<0.001, ****p<0.0001. n=3 per
group. I-L) Whole gastrocnemius mRNA expression following LPS-induced acute lung
injury. Ordinary 2-way ANOVA with Sidak multiple comparisons. Stars indicate
differences between treatments at a given timepoint. * p<0.05, **** p<0.0001. n=4-7 for
each treatment at indicated timepoints. M-P) Intramuscular cytokine concentration 3
hours following LPS-induced acute lung injury. Unpaired t test. *p<0.05. n=3 per group.
All data are displayed as mean ± SEM.
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Figure 2. C2C12 myotubes respond rapidly to TLR agonists. A-D) Cytokine
expression at indicated timepoints from myotubes differentiated for 7 days and treated
with LPS (1 μg/ml), Pam3CSK4 (1 μg/ml), or Poly(I:C) (50 μg/ml). Two-way ANOVA
with Dunnett multiple comparisons. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
Star colors correspond to significant differences between condition and control at given
timepoint. n=4 representative of 3 independent experiments. E-G) Cytokine secretion
from myotubes differentiated for 7 days and treated with LPS (1 μg/ml), Pam3CSK4 (1
μg/ml), or Poly(I:C) (50 ug/ml). Cell-free supernatants were quantified using ELISA.
Ordinary one-way ANOVA with Dunnett multiple comparisons. ****p<0.0001. n=3 per
experimental treatment. Data are representative of 3 independent experiments and are
displayed as mean ± SEM.

Macrophages synergistically increase cytokine production in C2C12 myotubes following
LPS stimulation
To understand the contribution of leukocytes to the muscle inflammatory
environment, co-cultures of bone marrow derived macrophages (BMDM) and C2C12
myotubes were established (C2C12+BMDM). Following treatment with LPS, co-cultures
(C2C12+BMDM+LPS) displayed a synergistic increase in the expression of Il6, and Ccl2
(Figures 3 A, B) compared to C2C12+LPS (p<0.0001). This increase was sustained for a
longer duration than C2C12+LPS alone. Protein data (Figures 3 E, F) verified this
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increase. Of note, a sufficient quantity of RNA was not obtainable in conditions
containing only BMDM at the numbers used in the co-culture system. Cxcl1 displayed
higher peak expression in C2C12+LPS compared to C2C12+BMDM+LPS (p<0.01,
Figure 3 C). Prolonged expression of this chemokine lead to a higher CXCL1 protein
content in BMDM+C2C12+LPS supernatants compared to C2C12+LPS supernatants at
24 hours (p<0.0001, Figure 3 G). TNF expression appeared to be synergistically
increased in the C2C12+BMDM+LPS compared to myotubes alone (C2C12+LPS;
p<0.0001, Figure 3 D). However, upon protein quantification, this difference was largely
attributed to BMDM expression of Tnf mRNA and secretion of TNFα protein (Figure 3
H). Lack of TNFα in C2C12+LPS supernatants was also seen following treatment with
Pam3CSK4 and Poly(I:C) (Figure 2 G).
To confirm that the TNFα measured in the C2C12+BMDM+LPS condition is
macrophage derived, BMDMs were generated using mice lacking a functional Tnf gene
(TNF-/-). Absence of BMDM-derived TNFα completely ablated synergistic increases in
Il6, Ccl2, and Cxcl1 (Figures 4 A-C). Protein quantification mirrored gene expression
measurements (Figures 4 E-G). Tnf and TNFα were expressed and produced,
respectively, only in conditions containing TNF+/+ macrophages (Figures 4 D, H).
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Figure 3. BMDM synergistically enhance IL-6, CCL2, and CXCL1, but not TNFα
production in LPS stimulated C2C12 myotubes. A-D) Cytokine expression of C2C12
myotubes alone or in co-culture with BMDM. Cells were treated with LPS (1 μg/ml) at
times indicated. Two-way ANOVA with Tukey’s multiple comparisons. *p<0.05,
**p<0.01 ***p<0.001, ****p<0.0001. Star colors correspond to significant differences
between the respective colored condition and C2C12 at given timepoint. Black stars
indicate significant difference between LPS and BMDM+LPS. n=4-8 per condition at
each timepoint. E-H) Cytokine protein secretion into cell culture supernatant. Treatment
and co-culture conditions are indicated, and supernatants were collected after 24h. Oneway ANOVA with Tukey’s multiple comparisons. **p<0.01, ***p<0.001,
****p<0.0001. n=8 per group. All data are displayed as mean ± SEM.

Figure 4. BMDM in co-culture are responsible for TNFα production. A-D) 4h
cytokine expression of C2C12 myotubes in co-culture with BMDM containing functional
(TNF+/+) and nonfunctional (TNF-/-) Tnf genes. Cells were treated with LPS (1 μg/ml).
One-way ANOVA with Sidak multiple comparisons. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001. n=4 per group. Data are displayed as mean ± SEM. E-H) 24h cytokine
secretion from myotubes and cocultures following treatment with LPS (1 μg/ml). Oneway ANOVA with Sidak multiple comparisons. *p<0.05, ***p<0.001, ****p<0.0001.
n=4 per group. Data are displayed as mean ± SEM.
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TNFα is sufficient and necessary to drive increased cytokine production in muscle
To investigate whether TNFα is sufficient to drive the synergistic increase in
cytokine production from LPS-stimulated myotubes, we treated myotubes with
recombinant TNFα (300 pg/mL) at the same concentration found during co-culture
conditions (Figure 5). Singular treatment with TNFα mimicked the C2C12+BMDM+LPS
treatment condition, showing a synergistic increase in Il6, Ccl2, and Cxcl1 at 2h
(p<0.0001, Figures 5 A-C). As expected, recombinant TNFα did not induce a meaningful
expression of Tnf (Figure 5 D). Tlr4 expression was significantly decreased upon the
addition of TNFα (Figure 5 E). Protein quantification from cell-free supernatants
confirmed qPCR data, with synergistic increases in IL-6, CCL2, and CXCL1 (Figures 5
F-I). At 24h, TNFα in the LPS+TNFα condition is likely residual recombinant protein
(Figure 5 H). Additional cytokine enhancing effects of TNFα were not seen in vivo
through intramuscular injections of LPS (10 ng/mouse), TNFα (50 ng/mouse), or a
combination of the two (Figures 5 J-M).
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Figure 5. TNFα is sufficient for synergistic increase in cytokine expression in vitro,
but not in vivo. A-E) Cytokine and Tlr4 expression from myotubes differentiated for 7
days and treated with LPS (1 μg/ml) ± recombinant mouse TNFα (300 pg/ml) and
collected at 4 hours. One-way ANOVA with Sidak multiple comparisons. *p<0.05,
**p<0.01, ***p<0.001, ****p<0.0001. n=8 per group. Data are displayed as mean ±
SEM F-I) Cytokine secretion from myotubes differentiated for 7 days and treated with
LPS (1 μg/ml) ± recombinant mouse TNFα (300 pg/ml). One-way ANOVA with Sidak
multiple comparisons. **p<0.01, ***p<0.001, ****p<0.0001. n=4 per group. Data are
displayed as mean ± SEM. Note that log scale has been used on the CXCL1 panel. J-M)
In vivo cytokine expression from murine gastrocnemius 3 hours after intramuscular
injections with saline, LPS (10 ng/mouse), recombinant TNFα (50 ng/mouse), or in
combination. Ordinary one-way ANOVA with Sidak multiple comparisons. *p<0.05,
***p<0.001, ****p<0.0001. n=5 per group. Data are displayed as mean ± SEM.
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To determine if TNFα is necessary to regulate cytokine production in response to
LPS, C2C12+BMDM co-cultures were treated with both LPS and anti-TNFα antibody
(Figure 6). Compared to the isotype antibody control, co-cultures receiving anti-TNFα
had diminished levels of cytokine expression of Il6, Ccl2, and Cxcl1 (p<0.0001, Figures
6 A-C). Il6, Ccl2, and Cxcl1 expression in the C2C12+BMDM+LPS+anti-TNFα group
were similar to the C2C12+LPS condition, ablating the effect of TNFα on the expression
of these cytokines. Tnf expression was unchanged between
C2C12+BMDM+LPS+isotype and C2C12+BMDM+LPS+anti-TNFα (Figure 6 D). 24
hour supernatant protein quantification of IL-6, CCL2 and CXCL1 reflect expression
levels of these genes at 4 hours (Figures 6 E-G), whereas TNFα protein levels also
reflected gene expression, except in the C2C12+BMDM+LPS+anti-TNFα group in which
TNFα was neutralized and not detectable in the ELISA. The in vivo necessity of TNFα to
induce cytokine expression was established through intramuscular injections of saline,
LPS (10 ng/mouse), and anti-TNFα or isotype antibody (10 μg/mouse). Significant
reductions in the expression of Il6, Ccl2, Cxcl1, and Tnf were seen in groups given
LPS+anti-TNFα antibody compared to LPS and LPS+isotype control groups. Expression
of Il6, Cxcl1, and Tnf in the LPS+anti-TNFα group were not significantly different from
saline injected mice. Taken together, these data indicate that TNFα drives the cytokine
increase observed in LPS-stimulated C2C12+BMDM co-cultures and is required for
cytokine expression in vivo.
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Figure 6. TNFα is necessary for synergistic cytokine increases in C2C12/BMDM
cocultures and in vivo in muscle. A-D) Cytokine expression from myotubes
differentiated for 7 days and co-cultured with BMDM then treated with LPS (1 μg/ml) ±
anti-TNFα antibody (10 μg/ml) or isotype control antibody (10 μg/ml). Ordinary one-way
ANOVA with Sidak multiple comparisons. *p<0.05, ***p<0.001, ****p<0.0001. n=8
per group. Data are displayed as mean ± SEM. E-H) Cytokine secretion from myotubes
differentiated for 7 days and co-cultured with BMDM then treated with LPS (1 μg/ml) ±
anti-TNFα antibody (10 μg/ml) or isotype control antibody (10 μg/ml) for 24h. Ordinary
one-way ANOVA with Sidak multiple comparisons. *p<0.05, ***p<0.001,
****p<0.0001. n=4 per group. Data are displayed as mean ± SEM. I-L) In vivo cytokine
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expression from murine gastrocnemius 3 hours after intramuscular injections of saline,
LPS (10 ng/mouse), and combinations of LPS and anti-TNFα antibody (10 μg/mouse) or
isotype control antibody (10 μg/ml). Ordinary one-way ANOVA with Sidak multiple
comparisons. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. n=5 per group. Data are
displayed as mean ± SEM.
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Discussion
The presented study casts light on the contribution of muscle to critical illness.
We find that muscle produces proinflammatory cytokines rapidly and at a time that
precedes maximal lung injury. This phenomenon was recapitulated in vitro with C2C12
myotubes and shown to be amplified by macrophages at densities within a range seen in
healthy skeletal muscle. Finally, we show evidence that this synergistic increase in
proinflammatory cytokines requires TNFα, with macrophages being an important source
of this cytokine. These data suggest that muscle may participate in the early inflammatory
response, a phenomenon which has historically been driven by the liver. The rapid,
transient secretion of cytokines by muscle likely contribute to initial inflammatory milieu,
priming a systemic response and leukocyte mobilization. While response to LPS was also
seen in liver, heart, lung, and spleen (data not shown), the contribution of skeletal muscle
to body mass is greater than the sum of these organs and should not be discounted.
Skeletal muscle expresses proinflammatory cytokines during critical illness (9)
and previously published data show that systemic cytokine levels can be modulated
through exercise, implicating muscle as a potential regulator of the local and systemic
inflammatory milieu (18). To determine the potential role of muscle, we conducted time
series studies using the murine IT LPS model of experimental ARDS (26). IT LPS
administration showed rapid and transient transcription of Il6, and transcription and
translation of Ccl2, and Cxcl1 in the gastrocnemius muscle within 3 hours of LPS
instillation (Figure 1 I-K, N, O), which precedes maximal pulmonary inflammation
(Figure 1 A, B). While protein translation is variable, we predict muscle is actively
secreting cytokines into circulation, leading to limited detection within muscle. Although
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skeletal muscle may not be the primary source of circulating IL-6 following IT-LPS, it
has been recently demonstrated using a skeletal muscle-specific Il6 knockdown mouse
(27) that skeletal-muscle-derived IL-6 contributes to systemic IL-6 levels and the
concentrations of TNFα and IL-10 in a model of polymicrobial sepsis. The contribution
of other skeletal muscle-derived cytokines to systemic inflammatory tone awaits future
studies.
To examine whether the rapid muscle inflammatory response is mediated by
circulating LPS, we administered FITC labeled LPS IT and measured serum fluorescence
to determine capillary leakage from the airspace (Figure 1 D). These experiments showed
that LPS appeared in serum within 30 minutes (data not shown) and was significantly
increased at 2 hours. Measurements of 1 μg/ml of LPS are lower than those used in
experimental models of IV LPS administration (28). Endotoxemia has been found in a
majority (>50%) of ICU patients (29) despite a comparatively low frequency of cultureproven, gram negative infection (30). In fact, leakage from the lumen of the digestive
track into the circulation has been reported in trauma (31, 32), burns (33), heat stress (34,
35), and non-bacterial infections (36-38). In patients, endogenous damage-associated
molecular patterns (DAMPs) and alarmins liberated during inflammation and from
damaged and dying cells could initiate a muscle inflammatory response via activation of
a variety of TLRs (39). Indeed, using our in vitro model, we found similar responses
among LPS, the TLR2 synthetic ligand, Pam3CSK4, and the TLR3 ligand, Poly(I:C)
(Figure 2). Thus, as with LPS in our IT LPS model, a range of ligands may combine with
acute lung injury to initiate an inflammatory response in muscle. We provide these data
to support the hypothesis that muscle is an active contributor to systemic immune
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responses to diverse innate immune stimuli. In this context, our model may better reflect
the complex array of stimuli (e.g., lung injury + endotoxemia) present in the clinical
syndrome of ARDS. This model additionally mimics the muscle wasting aspect of critical
illness, with muscle proteolytic machinery upregulated beginning at 24h (Trim63 data not
shown). While this is of significant interest and correlates with long term outcomes (6),
the transient cytokine expression led us to focus on the initial inflammatory response.
Due to the heterogeneity of cell populations within skeletal muscle, it is unclear
whether proinflammatory gene upregulation is a product of myocytes themselves, or if
other cells contribute. For instance, Borge et al. (40), who reported increased levels of
TNFα, IL-6, CCL2, and CXCL1 in plasma and muscle interstitial fluid following IT LPS
administration in Wistar rats, concluded that, due to the low number of macrophages
within muscle, there is little contribution of these cells to the inflammatory milieu. To
begin to examine this, we implemented an in vitro system using C2C12 myotubes and
BMDM, using LPS application at levels similar to those found in in vivo (Figure 1). Our
results show that myotubes alone recapitulated the response of muscle gene expression to
IT LPS in vivo, arguing that myofibers alone may be sufficient to induce an inflammatory
response. These data agree with previous studies using undifferentiated myoblasts treated
with LPS and other proinflammatory cytokines (41, 42). The myotube response to LPS
included robust expression of CCL2, which is of particular interest given the ability of
macrophages to modulate muscle cell biology (43, 44), including inflammation during
the early phase of muscle regeneration after injury (45). Thus, we modeled our myotube
culture system to include co-culture with BMDMs at an appropriate quantity within the
physiological range in uninjured skeletal muscle as assessed by histological approaches
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that are a superior comparison to our two-dimensional in vitro cell culture system than
are flow cytometric data (21, 23-25, 46, 47). Although this provided a limited quantity of
macrophages, we found an amplification of the inflammatory response in a non-additive
manner, increasing the duration of cytokine gene expression and augmenting the overall
secretion of IL-6, CCL2, and CXCL1 (Figure 3). As macrophage infiltration occurs in
skeletal muscle of ICU patients (8, 17), our data uncover a potentially novel role for this
cell type to amplify the muscle inflammatory response to LPS.
In singular myotube cultures, TNFα was not detected, but addition of BMDM
increased both expression and secretion IL-6, CCL2, CXCL1, and TNFα. Our data is
consistent with studies in human quadriceps biopsies following IV LPS administration,
which showed a modest, but non-significant, increase of TNFα within myofibers, as
assessed by in situ hybridization (48). We confirmed that only the BMDM were secreting
TNFα by generating BMDM from mice deficient in Tnf (Figure 4). By adding
recombinant mouse TNFα to C2C12 myotubes alone to the level detected in the coculture system (300pg/ml), and depleting TNFα within C2C12/BMDM co-cultures using
a neutralizing antibody, we demonstrate that TNFα is sufficient and necessary to for the
effects of BMDMs to enhance LPS-induced cytokine response from myotubes (Figures 5
and 6). Contrary to previous literature, TNFα alone did not induce substantial cytokine
increases in vitro, yet the differences in differentiation between myoblasts and myotubes,
and their subsequent responsiveness to TNFα stimulation, may account for the deviation
(49). It is unlikely that the cytokine enhancement by TNFα is due to receptor modulation
of TLR4 since expression of the receptor decreased at 4 h (Figure 5 E). Our in vivo
results confirm the necessity of TNFα to induce enhanced cytokine expression in skeletal
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muscle (Figure 6 I-L). Such a role for macrophage TNFα in orchestrating cellular
responses in muscle tissue is not unprecedented, as recent studies showed that
macrophage TNFα regulates fibrogenic cell populations following injury (50). More
broadly, macrophages can potentiate other cell-to-cell cross-talk during muscle
regeneration (51). Thus, these data add to a growing body of literature to suggest that
macrophages can modulate the behavior of muscle cells and other tissue resident cells.
The data presented herein demonstrate a potential role for spillover of IT
administered LPS into the circulation to incite an early skeletal muscle inflammatory
response. Moreover, the in vitro myotube model mimicked this inflammatory response
and showed that macrophages enhanced cytokine secretion in a non-additive fashion, an
effect that was dependent on macrophage-derived TNFα. Future studies aim to determine
the total contribution of muscle to the systemic inflammatory milieu following critical
illness, and if targeting macrophage infiltration or TNFα production might mitigate
intensive care unit acquired weakness and its sequalae.
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Abstract
The large abundance, widespread anatomical distribution, and high vascularity of
skeletal muscle make it an exemplary organ for rapid cytokine production and secretion
during inflammatory events. An orchestrated balance between pro- and anti-inflammatory
mediator production is necessary for proper immune function, yet the contribution of the
body’s largest organ system to this process is largely unknown. Endotoxin
(lipopolysaccharide, LPS) challenge stimulates toll-like receptor-4 (TLR4) to induce the
production of several pro-inflammatory cytokines, including interleukin-6 (IL-6) and C-C
motif chemokine ligand 2 (CCL2), by a myriad of cell types. We sought to quantify the
influence of skeletal muscle on systemic cytokine levels following an acute endotoxemia
challenge. To accomplish this, we generated muscle specific conditional knockouts for
TLR4 (TLR4SMKO), IL-6 (IL6SMKO), and CCL2 (CCL2SMKO). Using these receptor
and effector knockout mice, we administered low levels of intravenous
lipopolysaccharide (IV LPS) and collected samples after three hours. Using gene
expression analysis of gastrocnemius muscle and serum cytokine measurements, we
determined that deletion of skeletal myocyte TLR4 expression and stimulation leads to a
53% and 67% decrease in systemic CCL2 and C-X-C motif chemokine ligand 1
(CXCL1), respectively. Skeletal myocyte Il6 deletion significantly reduced systemic
levels of IL-6, whereas skeletal myocyte Ccl2 deletion did not affect plasma CCL2
levels. These data indicate that skeletal muscle myocytes may be critically involved
during the early systemic inflammatory cytokine response to endotoxin.
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Introduction
Cytokine balance during sepsis can determine outcomes of critically ill patients.
Whereas a robust and appropriately-timed immune response is required for successful
recovery from critical illness, excessive pro- and anti-inflammatory cytokines can alter
outcomes by injuring tissues or diminishing the immune response, respectively1. Skeletal
muscle’s contribution to the inflammatory environment can be altered by the extent of its
use, such as exercise2 or inactivity3, which prompted our current objective, and the work
of others4, 5, to determine the extent by which myofibers contribute to the systemic
cytokine milieu.
We have previously shown that muscle potently expresses and releases several
pro-inflammatory cytokines in a model of acute respiratory distress syndrome6. In this
model, bacterial lipopolysaccharide is delivered intratracheally, causing cellular influx to
the lung between 6 and 12 hours, and that persists for several days. Interestingly, muscle
transiently produces cytokines, peaking at 3 hours after injury. Follow up in vitro studies
showed that muscle myotubes synergize with macrophages to amplify LPS-induced proinflammatory cytokine production through macrophage-derived tumor necrosis factor α
(TNFα), yet the extent to which muscle feeds into the systemic cascade in vivo is still
under study4, 5. Systemic inflammatory response syndrome (SIRS) describes the process
of excess cytokine secretion that leads to organ disfunction7. During this dysregulated
response, blood coagulates8, vasculature permeabilizes9, and the overactivated leukocytes
induce non-specific organ damage10. Together, these processes result in poor outcomes
and death. Sepsis is the induction of SIRS during infection – during which elevated levels
of the cytokines IL-1β, IL-6, IL-8 (CXCL1), MCP-1 (CCL2), and IL-10 are predictive of
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poor prognosis11, 12. Since skeletal muscle potently secretes these pro-inflammatory
mediators, composes up to 40% of the body’s mass13, and is in important storage organ
for amino acids that are repurposed during critical illness14, 15, understanding the
contribution of myocytes to systemic inflammatory tone could provide information for
muscle-centric therapeutic strategies in critically ill patients.
To test the hypothesis that skeletal myocytes are a sensor of and cytokineproducing responder to TLR4-activating stimuli during the initial phase systemic
inflammation, we created a series of skeletal muscle myocyte specific knockout mice and
subjected them to an acute endotoxin challenge. Animals containing modified estrogen
receptor-Cre fusion (MerCreMer) constructs driven by a human skeletal muscle actin
promoter (HSA-MCM) were crossed with mice containing loxP sites adjacent to exons in
toll like receptor 4 (Tlr4, TLR4SMKO), interleukin-6 (Il6, IL6SMKO), and c-c motif
chemokine ligand 2 (Ccl2, macrophage chemoattractant protein 1, Mcp1, CCL2SMKO)
genes.
Following tamoxifen-induced deletion and intravenous (IV) LPS administration,
serum was analyzed for IL-6, CCL2, CXCL1, and TNFα. Gastrocnemius gene expression
for Tlr4, Il6, Ccl2, Cxcl1, and Tnf was also performed. Mice deficient in muscle TLR4
had pronounced decreases in circulating cytokines, with significant reductions in CCL2
and CXCL1. IL6SMKO serum showed reductions in IL-6. Interestingly, the
CCL2SMKO exhibited increased circulating IL-6, CCL2, and CXCL1 compared to WT
controls, despite no differences in muscle gene expression, implicating the involvement
of other tissues or interexperimental variability among knockout groups. Together, these
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data add to growing evidence4, 5 that skeletal muscle myocytes are an essential responder
to systemic pro-inflammatory agonists and contributor to systemic inflammatory tone.
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Methods
Mice
Animals were housed in AAALAC-accredited animal facilities at the University
of Vermont, and experimental animal procedures were approved by the University of
Vermont Institutional Animal Care and Use Committee (PROTO202000223). Mice were
maintained on a 12 hour-light/dark cycle, beginning at 07:00 and 19:00, respectively, and
provided irradiated chow (Prolab RMH 3000, Cat # 3005984-712, LabDiet, St. Louis,
MO) and autoclaved drinking water ad libitum.
Skeletal myocyte-specific gene knockout mice were generated by selectively
breeding heterozygous Tg(ACTA1-cre/Esr1*)2Kesr/J (Human skeletal actin promoter
driven MerCreMer double fusion protein, HSA-MCM, The Jackson Laboratory Cat #
025750, Bar Harbor, ME) with either B6(Cg)-Tlr4tm1.1Karp/J, (TLR4fl/fl, The Jackson
Laboratory Cat # 024872), B6.Cg-Ccl2tm1.1Pame/J (CCL2fl/fl, The Jackson Laboratory
Cat # #016849) or IL-6fl/fl mice 17. Wildtype controls were either littermates that
contained flanking loxP sites without the HSA-MCM construct or age matched
C57BL/6J mice (The Jackson Laboratory Cat # 000664). Mice were allowed to mature to
8 weeks before being given intraperitoneal injections of tamoxifen (75 mg/kg/day for 5
days, Millipore Sigma, St. Louis, MO) in corn oil to induce gene recombination.
Tamoxifen was allowed to washout for 3 weeks before subsequent experimental
procedures were conducted.
To confirm recombination, mouse gastrocnemius muscle was lysed, and DNA
was extracted using the Monarch Genomic DNA Purification Kit (New England Biolabs,
Ipswich, MA). Samples underwent PCR using iTaq Universal SYBR Green Supermix
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(Bio-Rad, Hercules, CA) with the following primers: Il6 Fwd –
CCCACCAAGAACGATAGTCA, Il6 Rev – ATGCCCAGCCTAATCTAGGT; Tlr4
Fwd – TCCTTGTTGCCCTTCAGTCAC, Tlr4 Rev – CCCCTGGAAAGGAAGGTGTC;
Ccl2 Fwd –TCTACACAGCCCCTCCATGT, Ccl2 Rev –
AAGAGTGGGCCATTCACTCTC (Integrated DNA Technologies, Coralville, IA) using
a C1000 thermocycler (Bio-Rad, Hercules, CA). PCR conditions: 1) 94°C 2:00, 2) 94°C
0:30, 3) 65°C 0:30, 4) 68°C 0:30 repeat 5) repeat 2-4 10x 6) 94°C 0:30, 7) 60°C 0:30 8)
72°C 0:30 9) repeat 6-8 28x 10) 4°C. PCR products were subjected to ethidium bromide
gel electrophoresis (1% agarose) and visualized using a GE Amersham 600 imager (GE
Healthcare, Chicago IL).
Acute endotoxemia
To model acute endotoxemia, we administered 1.5 μg (per ml of blood volume,
calculated to be approximately 1.5 ml per mouse18) of ultrapure 055:B5
lipopolysaccharide (Invivogen, San Diego, CA) intravenously to mice. This concentration
was derived previously by determining the leakage of LPS into the bloodstream
subsequent to intratracheal administration of 3 µg LPS/g mouse6. Three hours following
LPS administration, animals were euthanized by an intraperitoneal injection of
pentobarbital (Euthasol, Midwest Veterinary Supply, Lakeville, MN), followed by
exsanguination. Blood was collected, allowed to clot at room temperature, centrifuged at
21,300 x g, and serum was collected. Serum and dissected gastrocnemius muscle were
snap frozen in liquid nitrogen.
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Gene expression analysis
Gastrocnemius muscles were ground in liquid nitrogen using a mortar and pestle,
and RNA was isolated using Trizol and chloroform. Following purification, RNA was
treated with DNAse I (Invitrogen, Waltham, MA) and quantified using a Nanodrop
Spectrophotometer (Thermo Fisher Scientific, Waltham, MA). 100 ng of RNA was
converted to cDNA using qScript cDNA Supermix (Quantabio, Beverly, MA) and gene
expression was measured using iTaq Universal SYBR Green Supermix on a CFX96
Touch machine (Bio-Rad). Primer sequences for RT-qPCR are as follows: Gapdh Fwd ACGACCCCTTCATTGACCTC, Rev – TTCACACCCATCACAAACAT; Il6 Fwd TCCGGAGAGGAGACTTCACA, Rev – TTCCACGATTTCCCAGAGAACA; Ccl2
Fwd - GACCCCAAGAAGGAATGGGTC, Rev – TGCTTGAGGTGGTTGTGGAAA;
Cxcl1 Fwd - GCTGGGATTCACCTCAAGAA, Rev – TGGGGACACCTTTTAGCATC;
Tnf Fwd - TCCCAGGTTCTCTTCAAGGGA, Rev – GGTGAGGAGCACGTAGTCGG;
Tlr4 Fwd - CTGGCTGGTTTACACGTCCA, Rev – GCAGAAACATTCGCCAAGCA.
PCR conditions: 1) 95°C 2:00 2) 95°C 0:30 3) 58°C 0:30 4) 72°C 0:45 5) repeat 2-4 39x.
Serum protein quantification
Luminex based magnetic bead assays were used to for protein analysis of IL-6,
CCL2, CXCL1, and TNFα (R&D Systems, Minneapolis, MN) according to
manufacturer’s instructions on a Bio-Plex 200 system (Bio-Rad).
Data presentation and statistical analysis
Relative gene expression was determined using the 2-ΔΔct method. Graphing and
statistical analysis were performed on Graphpad Prism 9 (Graphpad Software, San Diego,
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CA). Figure 1A was created using Biorender.com. Data are presented as means ± SEM.
For comparisons in which standard deviations were not equal, groups were compared
using Brown-Forsythe and Welch ANOVA tests with Dunnett’s T3 multiple comparisons
against WT. When standard deviations were equal, ordinary one-way ANOVAs with
Dunnett’s multiple comparisons were performed.
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Results
Recombination of floxed genes in skeletal myofibers.
DNA was extracted from the gastrocnemius muscle of mice who underwent gene
recombination and intravenous LPS injections. A brief schematic for floxed constructs
and the PCR confirmation is shown in Figure 1A. Gene products, as visualized on
agarose gels, are depicted Figure 1B. The tissue specificity of the HSA-MCM mouse has
been repeatedly shown to be localized to fully developed skeletal muscle myofibers4, 5, 19.
Our results show abundant recombination of Tlr4, Il6, or Ccl2 specifically in the genetargeted mice.
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Figure 1 Confirmation of DNA recombination in skeletal muscle of targeted
mice. Human skeletal actin MerCreMer mice were crossed with mice containing
either floxed Tlr4, Il6, or Ccl2 and given intraperitoneal injections of tamoxifen
(75 mg/kg) for five consecutive days. A) Simplified schematic of TLR4, IL-6, and
CCL2 genomic constructs. B) PCR products from gastrocnemius muscle to
confirm Cre-mediated gene recombination. Due to the size of exon 3 of TLR4,
PCR amplification only occurs in recombined tissues. Data are representative of
all mice tested (N > 7/group).
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Myocytes constitute a significant proportion of LPS-induced cytokine-producing cells in
LPS-stimulated skeletal muscle
Our earlier in vitro work reported the capacity of skeletal myocytes to respond
directly to LPS and to subsequently express and produce several pro-inflammatory
cytokines6. To test whether these findings extend to the in vivo setting, gastrocnemius
muscles from myocyte-specific Tlr4-, Il6, or Ccl2-deleted mice were collected and first
analyzed for Il6, Ccl2, Cxcl1, Tnf, and Tlr4 expression three hours after LPS
administration (Figure 2). TLR4SMKO mice showed a significant 33.25% decreases in
the expression of Tlr4, accompanied by significant decreases in Il6, Ccl2, and Cxcl1. In
contrast, there was no effect on Tnf expression in TLR4SMKO Mice. Intriguingly, at the
time point measured, which was chosen based on the time of maximal LPS-induced gene
expression in skeletal muscle from earlier studies6, there were no decreases in Il6 or Ccl2
in IL6SMKO or CCL2SMKO mice. In contrast, the CCL2SMKO mice exhibited small
but insignificantly elevated expression of Il6 and Tlr4 in skeletal muscle compared to WT
mice.
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Figure 2 Skeletal muscle cytokine expression 3 hours after IV LPS.
Gastrocnemius muscle cytokine and Tlr4 expression from skeletal muscle specific
conditional knockouts for TLR4 (TLR4SMKO, n = 17), IL-6 (IL6SMKO, n =
10), CCL2 (CCL2SMKO, n = 7), or littermate controls (WT, n = 24). Values were
analyzed using 2-ΔΔct method and compared using a Brown-Forsythe and Welch’s
ANOVA (A-C, E) or one-way ANOVA with Dunnett’s multiple comparison test
(D). p<0.01 **, p<0.001 ***.

Skeletal muscle myocytes contribute to systemic cytokine production.
To determine the impact of skeletal myocyte-specific deletion of Tlr4, Il6, or Ccl2
on systemic inflammatory tone, IL-6, CCL2, CXCL1, and TNFα were measured in serum
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collected 3 hours following LPS challenge (Figure 3). TLR4SMKO mice showed
significant 53% and 67% decreases in CCL2 and CXCL1, respectively, whereas there
were no decreases in serum IL-6 concentrations. In contrast, circulating IL-6
concentrations significantly decreased by 91% in IL6SMKO mice. Finally, serum from
CCL2SMKO mice had markedly higher levels of IL-6, CCL2, and CXCL1 (555%,
305%, and 73% respectively) compared to WT mice. The knockout strains showed no
differences in serum TNFα concentrations compared to WT mice.

Figure 3 Skeletal muscle cytokine secretion influences systemic cytokine
levels. Serum collected from mice containing skeletal muscle specific conditional
knockouts of TLR4 (TLR4SMKO, n = 17), IL-6 (IL6SMKO, n = 10), CCL2
(CCL2SMKO, n = 7), or littermate controls (WT, n = 24) was measured for
concentrations of IL-6 (A), CCL2 (B), CXCL1 (C), and TNFα (D) 3 hours after
IV LPS. Data were compared using Brown-Forsythe and Welch’s ANOVA (A-C)
or one-way ANOVA with Dunnett’s multiple comparison test (D). p<0.05 *,
p<0.01 **, p<0.001 ***.
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Discussion
For these studies, we implemented a low dose endotoxemia model to determine
the extent to which skeletal muscle myocytes contribute to the systemic inflammatory
milieu. To quantify this response, we used a series of skeletal muscle specific
knockdowns of a receptor and effectors involved in critical illness. We found that
removal of TLR4 from skeletal muscle myocytes resulted in decreases in the chemokines
CCL2 and CXCL1 in serum. These decreases paralleled gene expression analysis in the
gastrocnemius muscle. The effector knockouts of IL-6 and CCL2 had markedly different
results. IL6SMKO mice had significantly reduced serum IL-6, indicating that skeletal
muscle derived IL-6 contributes a substantial proportion to the systemic concentrations of
this cytokine. CCL2SMKO mice showed increases in serum IL-6, CCL2, and CXCL1.
This interesting response contrasts the TLR4SMKO data, which showed that removal of
the receptor blunted CCL2 from muscle. Mice were utilized as they were bred over the
course of several months, so one possible explanation for variability in our studies could
be interexperiment variability accounting for the higher serum cytokines in the cohorts of
CCL2SMKO mice and accompanying WT mice that were studied at the end of our
experiments.
Our model of acute endotoxemia mimics SIRS-like cytokine pathology and was
derived from a model of intratracheal LPS administration. Lung leakage following injury
allowed LPS to enter circulation and was measured systemically shortly after
administration of the injurious LPS dose6. Therefore, to decrease potential confounding
variables of lung injury, we proceeded to use these measured systemic LPS values for our
IV injections. Since IV LPS is cleared by the liver rapidly with a half-life of only 2-4
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minutes20, the model we employed provides a rapid burst of primary cytokines that is not
perpetuated by infections such as those present in cecal slurry or cecal ligation methods21.
Thus, our IV LPS model enabled us to determine skeletal muscle’s contribution to local
and systemic pro-inflammatory biomarker and mediator production from the first TLR4
signaling events.
Recently, Laitano and colleagues reported on the involvement of skeletal muscle
myocytes in sepsis using two similar knockout models. Using the same skeletal musclespecific, tamoxifen-inducible deletion strategy, their group targeted MyD885, one of the
two adaptor proteins recruited to TLR4 upon its stimulation, and the cytokine IL-64. Mice
were injured with intraperitoneal injections of cecal slurry and euthanized at 6 and 12
hours. In the skeletal myocyte MyD88 knockout, there were varied decreases in proinflammatory responses, with decreases in TNFα and CCL2, but no changes in IL-6 and
CXCL1 concentrations in serum. In the skeletal myocyte IL-6 knockout, there were
significant decreases in TNFα, IL-6, and CXCL1. The decreases were accompanied by
decreases in IL-10 and IL-4. The reduction of these anti-inflammatory cytokines may
account for the increases in peritoneal neutrophils seen in both knockouts. Muscle gene
expression was not measured.
In agreement with our data, these studies show the importance of skeletal muscle
in the pathogenesis of sepsis and endotoxemia; however, some differences exist. Whereas
our experiments show differences at early time points, the previous studies report
minimal to no differences until 6 hours after injury. This disparity is likely due to the
injury models used. The proliferation and migration of intraperitoneal cecal bacteria may
create a temporal delay from injection to muscle response, whereas intravenous injections
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of LPS are immediate and display more pronounced and rapid kinetics22, 23. Sex
differences were also reported in the studies of Laitano et al. Specifically, nearly all the
decreases in cytokines were limited to female mice, with little to no change among male
mice at both 6- and 12-hours following injury4, 5. In contrast, there were no intragenotype
sex dependent effects in our 3-hour endotoxemia model (Supplementary Figure S1).
There is vital importance to the onset of inflammation. Particularly in stimulation
of the compensatory anti-inflammatory response. If the response of anti-inflammatory
cytokines such as IL-4 and IL-10 overcompensate for the initial wave of inflammation, it
opens susceptibility for future infection or inability to fight the current one24. Since IL-10
shares with pro-inflammatory cytokines regulation by the transcription factor, NF-κB25, a
possible consequence of MyD88 or TLR4 removal from skeletal myocytes could be
decreased compensatory, anti-inflammatory cytokines. However, cytokines are not
exclusive in resolving inflammatory events. Lipid based molecules such as resolvins and
protectins have been shown to be vital in resolving muscle derived pro-inflammatory
cytokines26. The enzymes to make these anti-inflammatory mediators have been found to
be upregulated in muscle following LPS treatment, and future studies should investigate
muscle’s role in resolving inflammation through this mechanism26.
While this study and others measure decreases in systemic cytokine production,
they are unable to determine whether these come directly from skeletal muscle, or if there
are other cell crosstalk intermediates. Our in vitro studies revealed the amplifying effects
of macrophage-derived TNF on LPS-induced pro-inflammatory cytokine production from
co-cultured C2C12 skeletal myocytes6. It is certain that this and additional examples of
cell-cell communication axes are at play in muscle in vivo. Further confirmation could be
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accomplished using the secretome mouse, which researchers are able to identify the
origins of proteins27, or by using a multi-omics approach and modeling genome-wide
changes in muscle gene expression to changes in serum proteins. Regardless of whether
signaling from other cell types account for the differences we observed using these
knockout mice, or if the changes in systemic cytokines are directly due to skeletal
myocyte deletions, it is clear that muscle’s inflammatory burst should not be
underappreciated.
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Supplemental Material

Figure S1 Evaluating the effect of sex on systemic cytokine levels. Data from Figure 3
has been segregated by sex and evaluated using a two-way ANOVA with multiple
comparisons. p< 0.0001 ****.
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Abstract
Current methods of small animal exercise involve either voluntary (wheel
running) or forced (treadmill running) protocols. Although commonly used, each have
several drawbacks which cause hesitancy to adopt these methods. While mice will
instinctively run on a wheel, the distance and time spent running can vary widely. Forced
exercise, while controllable, puts animals in stressful environments in which they are
confined and often shocked for “encouragement.” Additionally, both methods require
expensive equipment and software, which limit these experiments to well-funded
laboratories. To counter these issues, we developed a non-invasive mouse running device
aimed to reduce handler-induced stress, provide time and distance based stopping
conditions, and enable investigators with limited resources to easily produce and use the
device. The Lockable Open-Source Training-Wheel (LOST-Wheel) was designed to be
3D printed on any standard entry-level printer and assembled using a few common tools
for around 20 USD. It features an on-board screen and is capable of tracking distances,
running time, and velocities of mice. The LOST-Wheel overcomes the largest drawback
to voluntary exercise, which is the inability to control when and how long mice run, using
a servo driven mechanism that locks and unlocks the running surface according to the
protocol of the investigator. While the LOST-Wheel can be used without a computer
connection, we designed an accompanying application to provide scientists with
additional analyses. The LOST-Wheel Logger, an R-based application, displays
milestones and plots on a user-friendly dashboard. Using the LOST-Wheel, we
implemented a timed running experiment that showed distance-dependent decreases in
serum myostatin as well as IL-6 gene upregulation in muscle. To make this device
accessible, we are releasing the designs, application, and manual in an open-source
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format. The implementation of the LOST-Wheel and future iterations will improve upon
existing murine exercise equipment and research.
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Introduction
While exercise is a safe and effective health strategy [1], the ability for
laboratories to test hypotheses concerning the physiological adaptations brought about by
movement in mouse models is hindered by the expense of commercial products [2]. To
understand the systemic effects of untrained exercise and lower the barrier of entry for
murine-exercise research, we have developed an open-source mouse running wheel that
accurately tracks and displays the distance traveled and restricts wheel running at
specified distances or times. The Lockable Open-Source Training Wheel (LOST-Wheel)
has been designed for both standalone and computer connected scenarios. The only
requirement for standalone mode is a USB power source. In this mode, the LOST-Wheel
can log cumulative distance, which is visualized through the onboard screen. When a
computer is connected to the wheel through the LOST-Wheel Logger application, more
detailed data such as speed and time running can be collected, graphed, and exported.
The LOST-Wheel was tested in both overnight (acute) and week-long (chronic)
experiments. Samples from the acute, untrained, bout of exercise were subjected to
analysis with real-time quantitative polymerase chain reaction and protein quantification
through Luminex assays.
This design of the LOST-Wheel was inspired as an attempt to create an
inexpensive, freely accessible, and human-relevant model of exercise. One drawback of
voluntary exercise is the inability to limit running distances [3]. For studies that
interrogate the dose dependent effect of exercise or to restrict running to certain times and
distances, we implemented a microcontroller regulated locking mechanism to prevent
wheel movement at the will of the investigator. Previous work using commercially
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available products has shown that wheel running produces dose-dependent effects on
neuron proliferation and dendritogenesis [4]. Additionally, that the presence of an
immobile wheel in a cage also elicits neurological effects in the absence of its use
demands that such a device-exposure group should be included as a proper control in
wheel-running experiments [4, 5]. Despite the average gait of a mouse being 5-6 cm [6],
mice voluntarily run upwards of 7 hours and 20 km/night [3] when provided with a
standard wheel [7, 8]. The use of a wheel for long periods cannot be explained by a single
theory [9], and physiological effects differ substantially between strains of mice [10]. By
limiting running distances, the locking capacity of the LOST-Wheel enables researchers
to normalize voluntary exercise across animals. While forced exercise (treadmill running)
is an alternative strategy that ensures a consistent distance across animals, the handling
[11], confinement [12], and electrical shock [13] required for its implementation can
induce stress and alter the biological responses being studied [14].
To verify the effectiveness of the LOST-Wheel and to evaluate the consequences
of a single, untrained bout of exercise, we allowed a cohort of mice to perform voluntary
exercise for a single night (their waking time) then performed RT-qPCR on
gastrocnemius muscle and multiplex analysis of several myokines in serum. We
confirmed exercise-induced physiological changes, including increases in gastrocnemius
Il6 gene expression and a significant, negative, relationship between serum myostatin and
the distance traveled by mice.
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Methods
LOST-Wheel design and code
The LOST-Wheel was designed using Fusion360 (Autodesk, San Rafael, CA) and
is composed of four pieces: main body, top face, servo pin, and wheel. Table 1 contains a
component list for the electronics, bearings, axle, and hardware. Slicing the models for
3D printing was conducted using Cura (Ultimaker, Utrecht, Netherlands). All pieces were
printed using fusion deposition modeling with polylactic acid (PLA) on an Ender3 V2 3D
printer (Creality 3D, Shenzhen, China). The sketches used to program the LOST-Wheel
were created in Arduino IDE (Arduino, New York City, NY) in Arduino/C++ language
with the additional libraries, U8g2 and U8x8. A computer rendering, representative
image, and wiring diagram for the LOST-Wheel are shown in Fig. 1A, B, and C,
respectively. In acute exercise experiments, the Timer Mode protocol was uploaded and
set to begin when the wheel was powered on. For chronic exercise, the Distance Mode
protocol was uploaded and the threshold set to 106 m for unlimited running. The LOSTWheel can be powered indefinitely; however, in the experiments of this manuscript, data
was collected daily, at which time wheels were reset.
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Component
6 mm ID, 10 mm OD, x 3 mm bearing
6 mm axle cut to 65 mm
M3x5 self-tapping screw
M2x6 self-tapping screw
M2.3x8 self-tapping screw
M1.7x6 self-tapping screw
10 mm x 5 mm x 3 mm neodymium magnet
22-gauge, 2.54 mm breadboard jumper wires, 3 male, 7 female

Quantity
3
1
1
1
8
8
2
10

Arduino Nano (or similar)
9g micro servo
KY-003 hall effect sensor
0.96 inch 128x64 OLED Screen I2C connection SSD1306 Driver

1
1
1
1

Table 1 Component list for the LOST-Wheel. This list serves as a
template for the electronics and hardware required for the device. Generic
Arduino clones can be substituted as microcontrollers since they are often a
fraction of the price. Magnet size and quantity can also be changed depending on
availability and accuracy required.

All files required to build and program the LOST-Wheel are available at
https://github.com/jjbivona/LOSTwheel. The LOST-Wheel design files, manual, and
LOST-Wheel Logger software are licensed under a Creative Commons AttributionNonCommercial-ShareAlike 4.0 International License. To access a build video and setup
tutorial, visit: https://www.youtube.com/channel/UCUp9zD0H99VcX0XXl2qGUmg.
LOST-Wheel Logger
While the LOST-Wheel can accurately display distance using its onboard screen,
more detailed information can be obtained using the LOST-Wheel Logger Application.
The application was created in R and RStudio (version 4.1.1 and 1.4 respectively) using
Shiny [15], ggplot2 [16], and Serial [17] packages. Users are instructed to enter an ID for
the wheel, the associated communication port (COM port), and the duration of data
collection. After information is entered and the start button is pressed, the logger restarts
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the wheel and collects data in one second intervals until the duration is met. The program
then calculates the individual slopes between each data point to determine the maximum
speed in meters/second. Using this information, the Logger can determine the amount of
time the mouse has run. Previous literature indicates that untrained mice have an average
speed of 1-2 km/h (0.28-0.56 m/s) [18]; therefore, a threshold of 0.2 m/s is applied to
exclude non-running events. Finally, the LOST-Wheel Logger creates distance/time and
velocity/time graphs and presents all information for the user. The number of wheels that
can be simultaneously connected is limited by the number of universal serial bus (USB)
ports available on the computer. In our laboratory, we use an inexpensive USB hub to
expand the number of wheels connected. The current version of the LOST-Wheel Logger
accommodates a single wheel. Therefore, to collect data from multiple wheels, the user
must open a separate instance of RStudio for each wheel.
Mice
12-20 week old male C57BL/6J mice purchased from The Jackson Laboratory
(Bar Harbor, ME) were housed in AAALAC-accredited animal facilities at the University
of Vermont, and all experimental animal procedures were approved by the University of
Vermont Institutional Animal Care and Use Committee, protocol #202100027. Mice
were maintained on a 12 hour-light/dark cycle, beginning at 07:00 and 19:00,
respectively, and provided chow and water ad libitum.
To examine the effect of a single, untrained bout of exercise, mice were brought
from the vivarium and caged individually. A single LOST-Wheel, or an immobile
“dummy” wheel, was introduced into each cage at 08:00. Wheels in the running group
remained unlocked to acclimate the mice until 12:00, at which point the wheels locked.
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At 19:00 the wheels unlocked, and mice were allowed to run voluntarily for 12 hours, at
which point they were euthanized by an intraperitoneal injection of pentobarbital
(Euthasol, Midwest Veterinary Supply, Lakeville, MN), followed by exsanguination.
Serum and gastrocnemius muscle were collected and snap frozen in liquid nitrogen.
For one week running experiments, wheels remained unlocked throughout the
duration of the test. Distances were recorded at 09:00 each morning and the wheels were
reset.
RNA isolation, quantitative real-time polymerase chain reaction (qRT-PCR), and protein
quantitation
Total RNA was isolated from liquid nitrogen pulverized whole muscle using
TRIzol reagent followed by a chloroform-isopropanol extraction (Thermo Fisher
Scientific, Waltham, MA, USA). RNA concentration and purity were measured using a
NanoDrop 2000 spectrophotometer. (Thermo Fisher Scientific). cDNA was synthesized
from 100 ng of RNA using the qScript Supermix reagent kit per manufacturer’s
instructions (Quantabio, Beverly, MA, USA). Quantitative real-time PCR was performed
using iTaq Universal SYBR Green Supermix on a CFX96 Touch (Bio-Rad, Hercules,
CA, USA), with the relative mRNA expression calculated using the threshold cycle (Ct;
2−ΔΔCt) method normalized to Gapdh expression. The following primer sequences were
used (Integrated DNA Technologies, Coralville, IA, USA): Il6 forward 5’CCCGGAGAGGAGACTTCACAG-3’, reverse 5’-GAGCATTGGAAATTGGGGTA-3’;
Gapdh forward 5’-ACGACCCCTTCATTGACCTC-3’, reverse 5’TTCACACCCATCACAAACAT-3’.
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Serum samples were analyzed using a Milliplex Mouse Myokine Magnetic Bead
Panel (Millipore Sigma, St. Louis, MO, USA) on a Luminex 100 xMAP Instrument (BioRad) according to kit instructions.
Statistical Analysis and Figures
RT-qPCR and Milliplex data were analyzed and visualized using GraphPad
Prism version 9.2.0 for Windows (GraphPad Software, San Diego, CA, USA) with
unpaired t-tests and a linear regression, respectively. Significance is designated by pvalues < 0.05. Fig. 2a was created with BioRender.com.
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Results
Building and testing the LOST-Wheel
All components in Table 1 are readily available and the 3D printed models can be
created using any entry-level 3D printer capable of printing in polylactic acid (PLA)
filament. The wheel can be assembled using only a #1 Phillips head screwdriver, a
soldering iron, and a wire cutter/stripper. Excluding a 3D printer, the entire apparatus can
be created for less than 15 USD. The models can easily be modified to account for larger
diameter bearings and drive shafts, additional wheel magnets, or changes in component
mounting holes. A representative rendering and completed wheel are shown in Fig. 1A
and 1B, respectively. A simplified component wiring diagram is shown in Fig. 1C. We
have also created a series of videos that outline the assembly, programming, and cage
setup, which can be accessed at
https://www.youtube.com/channel/UCUp9zD0H99VcX0XXl2qGUmg.
The LOST-Wheel was tested for 7 days to evaluate durability and animal safety,
during which mice steadily increased distance traveled per day (Fig. 1D), averaging
2046.38 ± 2647.11 m on the first day and 8972.71 ± 2888.14 m at the end of the trial.
One mouse did not use the wheel until the second day.
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Figure 1 Lost-Wheel assembly and testing. A) Computer rendered design of the
assembled LOST-Wheel. B) Completed assembly of the LOST-Wheel. C) Simplified
wiring diagram of components. 22-gauge, 2.54 mm breadboard jumper wires are soldered
to the microcontroller and connected to components using the attached plugs. Should a
single component fail, this allows for easy replacement without resoldering. D) The
LOST-Wheel Logger application can be used in conjunction with the LOST-Wheel to
collect and plot additional data. E) Mice were allowed to run unrestricted for 7 days on
the LOST-Wheel. Each morning, the distance was recorded, and wheels were reset (n=5).

Locking criteria
To limit and control mouse exercise, we developed three separate modes for the
LOST-Wheel. These are first edited by the user based on their experimental requirements
and uploaded to the wheel through the Arduino IDE program. In Timer Mode, the user
inputs the amount of time (in hours) for which they want the wheel to be sequentially
locked and unlocked. This program was implemented for our acute voluntary exercise
experiments. The second and third modes limit exercise by distance and time spent
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running, respectively, and allow for the normalization of exercise across animals within
experimental groups.
Acute voluntary exercise by untrained mice
To examine the effects of a single bout of voluntary exercise on untrained mice,
we subjected mice to a one-day acclimation and exercise protocol (Fig. 2A). Mice were
singly placed in cages containing either a LOST-Wheel or an immobile “dummy” wheel
at 08:00. The wheel remained unlocked for four hours for acclimation, at which point the
servo inserted a pin into the wheel to lock the device (12:00). At 19:00, the pin was
withdrawn, and mice were allowed to voluntarily use the wheel for 12 hours. At the end
of exercise, we collected serum and leg muscles, then measured expression and
production of interleukin-6 (IL-6), a muscle-produced cytokine (myokine) reported to be
induced in exercised human subjects [19] as well as in mouse models of acute exercise
[20] and myostatin. We observed a significant increase in the expression of Il6 in the
gastrocnemius muscle following acute exercise (Fig. 2B). Interestingly, there was a
significant correlation between distance traveled on the LOST-Wheel and serum
myostatin measured by Luminex (Fig. 2C). One mouse did not log any distance on the
LOST-Wheel. This mouse was excluded from RT-qPCR measurements but included in
measurements of serum myostatin as a sedentary control.
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Figure 2 Acute exercise of untrained mice. A) Experimental setup. Mice were
acclimated to the LOST-Wheel for four hours, at which point the wheel locked until the
evening. Mice were allowed to run unrestricted for 12 hours, at which point the wheels
relocked and mice were euthanized. B) RT-qPCR analysis of gastrocnemius muscle Il6
expression (n=6-7/group, unpaired t test). C) Serum myostatin concentrations relative to
the distance traveled of mice undergoing untrained acute exercise (n=6, simple linear
regression).
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Discussion
This manuscript presents an open-source mouse wheel that can be affordably and
efficiently assembled by investigators. The LOST-Wheel can be used in standalone mode
to collect data on overall distances traveled. When used in combination with a computer,
the wheel interfaces with the LOST-Wheel Logger application to calculate the amount of
time spent running and top speed achieved. Finally, we verified the integrity of the device
and observed physiological changes in serum and muscle gene expression from a single
untrained bout of exercise.
Physiological alterations after running
While the primary objective was to assess the efficacy of the LOST-Wheel, there
was merit in observing the effects of acute exercise. Muscle derived signaling molecules,
termed myokines, are released during muscle contraction and indicate physiological
adaptations following exercise. Most notably, IL-6 is highly upregulated and is believed
to function differently from classic inflammatory signaling by instead increasing glucose
sensitivity and uptake [21]. We observed increases in Il6 expression in the gastrocnemius
muscle (Fig. 2B); however, increased IL-6 protein concentrations were not detected in
serum using a myokine multiplex panel, implicating its local effect in the muscle.
Additionally, we observed a significant, negative, correlation between distance traveled
and serum myostatin concentrations (Fig. 2C). As a regulator of muscle growth and
differentiation [22], this correlation implies that myostatin is dose dependently regulated
by running distance. These results align with previous studies in humans and rats, in
which myostatin was transiently decreased after bouts of acute exercise [23, 24].
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Voluntary exercise versus forced exercise
While treadmill based forced exercise allows for controlled speed, duration, and
incline of training, it increases corticosterone and norepinephrine levels, indicating a
strong stress response that is not elicited by during voluntary exercise [25-28]. The shock,
confinement, or handling of the mice can all contribute to the increased stress reported.
Additionally, the presence of an immobile wheel can have the added benefit of
environmental enrichment [29, 30]. Due to this effect, we advise using a locked LOSTWheel or creating a dummy wheel (fully assembled without electronic components) for
control groups [4, 5].
Durability of the LOST-Wheel
Several iterations of the LOST-Wheel were prototyped before using the Hall
effect sensor and magnet combination. Originally, the wheel rotated on a rotary encoder,
an electro-mechanical part that has a finite number of rotations (30,000-100,000) before
wearing out. We also attempted using an infrared sensor, but cage bedding would often
block the beam, rendering it useless. The magnet and Hall effect sensor bypass these
problems and should remain operational indefinitely. The running surface and shaft can
easily be removed and sprayed with ethanol to disinfect between uses. While mice have
occasionally chewed the running surface, this has not hindered its balance or
performance. We have also designed and provided a guard for the power cord that
protects it from destructive animals.

Comparison to existing wheels
To verify data collection on the LOST-Wheel, we have compared our 7 day
protocol to the well detailed and extensive work of DeBono and colleagues [18], who
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developed a method to track distances run by mice but that lacks the ability to limit
exercise, requires an expensive data acquisition unit with software (Spike 2,
https://ced.co.uk/prices/1401options, https://ced.co.uk/prices/softwareprices), and has
limited customizability and programmability. We have developed the LOST-Wheel
Logger App, which allows for detailed collection, analysis, and export of data similar to
the Spike 2 program. Reassuringly, our device recapitulates the distances reported in the
aforementioned work. Recently, an open-source wheel was introduced that tracks running
distances using a similar Hall Effect sensor as the LOST-Wheel. However, this device
does not allow for controlled exercise or additional data collection as it only collects
cumulative distance measurements [31]. Forced exercise designs exist that can be used to
exercise mice, but such devices require extensive machining and calibration [32] or the
repurposing of an existing human-treadmill [33].
Cost
The LOST-Wheel provides an inexpensive alternative to commercial murine
exercise devices. Similar distance tracking devices, without locking abilities, cost 300400 USD per wheel, require an additional data acquisition unit (400-900 USD), and
necessitate accompanying software (800-2500 USD) (price quotes are from
correspondence with commercial retailers). The availability and shallow learning curve
of Arduino-based microcontrollers allows for laboratories to create their own devices at a
fraction of the price [34]. The 3D printed parts can be outsourced to university fabrication
labs, commercial 3D print operations, or fabricated in-house as entry level fused
deposition modeling printers have substantially decreased in price over the last decade,
with entry level printers ranging from 200-300 USD.
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Future designs
The LOST-Wheel was created out of necessity and to improve current researchbased exercise protocols in experimental animals. We have shown that this inexpensive,
open-source wheel can provide investigator-controllable exercise to small rodent research
without modification of the cage. The value of an open-source project is that it allows
researchers to easily implement changes that fit their research goals and budgets. Future
iterations of the LOST-Wheel and Logger App can include wireless transmission of data
to a smartphone through commercially available Bluetooth-Arduino adaptors. Other
changes may include on-board data storage, operant conditioning modifications, or using
the locking pin to provide resistance against the wheel to model weighted wheel
hypertrophy-inducing exercise [35].
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CHAPTER 5: DISCUSSION
5.1 Summary and conclusion
The previous three chapters of this dissertation explore the intercellular molecular
communication of the muscle-macrophage microenvironment, evaluate the contribution
of a skeletal muscle myocyte pattern recognition receptor and myocyte-derived cytokines
to the local and systemic inflammatory milieu, and make strides toward improving
models of murine exercise, respectively. These three topics are illustrated in the graphical
summary below.

Chapter 2 demonstrates that early in the process of LPS induced acute lung injury,
skeletal muscle rapidly and transiently upregulates pro-inflammatory cytokines, a process
that can be augmented by macrophage-derived TNFα. Since muscle is a heterogenous
population of cells, we reduced our intratracheal LPS approach to an in vitro model using
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C2C12 myotubes. These differentiated monocultures allowed us to confirm that muscle
was the likely source of these cytokines. We then generated cocultures using BMDMs
and C2C12 myotubes to investigate the interactions between innate leukocytes and
myocytes. When combined, cytokine expression and secretion synergistically increased
following LPS stimulation, with most increases attributed to the myotubes. By comparing
the monocultures of BMDMs and C2C12s, we observed that the BMDMs were secreting
TNFα and that the C2C12 myotubes had little to no expression and secretion of this
cytokine. We hypothesized that BMDM derived TNFα was sufficient and necessary to
increase the LPS-induced cytokine response observed in coculture experiments.
Therefore, we added recombinant TNFα or neutralized TNFα using antibodies. In vitro,
TNFα is both sufficient and necessary to induce synergistic cytokine increases following
myotube LPS stimulation. When we injected LPS and either recombinant TNFα or
antibody into the gastrocnemius muscle of mice, we found that the cytokine was
necessary for complete pro-inflammatory cytokine expression in whole muscle.
After determining the interaction between muscle and macrophage, we
hypothesized that the skeletal muscle response has a substantial systemic impact during
critical illness. We generated three novel muscle-specific knockout mouse strains to
quantify the cytokine burden from muscle using a model of endotoxemia. This
minimalistic model allowed us to remove any confounding or compounding effects of
lung injury, while mimicking the amount of LPS leakage measured in the circulation
from our earlier lung injury studies. Serum analysis determined that removal of the LPS
receptor, TLR4, from muscle significantly decreases circulating CCL2 and CXCL1. In
agreement that muscle is actively secreting cytokines following TLR4 stimulation, our
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IL-6 muscle conditional knockouts showed reduced serum IL-6. To improve upon this
study and more thoroughly examine, both qualitatively and quantitatively, the broad
secretion pattern of muscle, an unbiased approach should be taken through either RNA
sequencing or broader protein screens. We conducted an unbiased assessment of the
serum proteome from wildtype naïve as well as LPS-exposed wildtype, IL6SMKO and
TLR4SMKO mice, which was insufficiently sensitive to detect altered concentrations of
the hypothesized biomarkers. Similarly, attempts at assessing skeletal muscle gene
expression from the aforementioned mice using RNAseq remain ongoing. Nevertheless,
the results we were able to provide support the hypothesis that muscle contributes an
appreciable amount of proinflammatory cytokines during the early phases of systemic
illness.
Finally, this dissertation presents an improved method of voluntary mouse
exercise. The LOST-Wheel will enable researchers to easily and affordably limit exercise
in mice and consistently track distance, time running, and velocity. Whereas some
commercial products have similar features of the LOST-Wheel, their high price point,
need for peripheral equipment, and requirements for cage modification make using them
inaccessible for many laboratories. The open-source design and open-access publication
of the LOST-Wheel will hopefully undercut these overpriced commercial products.
Collectively, this dissertation adds to the scientific community a novel mechanism
of muscle-leukocyte crosstalk during critical illness, evidence that skeletal muscle is an
active organ during sickness, and a new device for exercise-based research.
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In a similar style to the introduction, this discussion will not repeat the previous
journal articles, and the remainder of this chapter will highlight some of the additional
research that alone do not tell a complete story, but merit inclusion in this dissertation.

5.2 The influence of a pandemic on future directions
On March 25th, 2020, the University of Vermont shuttered its doors to prepare for
a statewide shutdown. At the time, we were given only a few hours’ notice to stop
experiments, freeze cell lines, and gather what we needed to work from home. At 4:30
PM, I took my hard drives, a monitor, and notebooks to prepare for what seemed like the
end of the world. I sat in my car and watched as other graduate students, postdoctoral
fellows, technicians, and professors rushed in and out of the research complex. A younger
professor had a cart with four desktop computers trying to carefully navigate over the
sidewalk curb. An older professor had his arms filled with notebooks that were
haphazardly and chaotically filled with loose papers. It was a surreal moment to see
decades of research and progress being frantically relocated. We attended our meetings
from the couch, wrote grant applications and papers on the kitchen table, and tried to
impersonate Isaac Newton, who wrote the foundations of modern calculus during a
shutdown at Trinity College. In retrospect, there was no need to bring the stacks of
notebooks home, as the building was still standing when we returned on June 1st, but the
shutdown afforded time to think deeper about current research topics. First, scientific
communication from both scholars and government agencies was poor, leading to
misinterpretations and misinformation. Second, and more optimistically, was that mRNA
vaccine technology was about to transform biomedical sciences and the whole of society.
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5.3 A brief foray into scientific communication
Precise language is necessary in scientific discourse, and researchers have
developed a complex lexicon to be as accurate as possible. The intricacies of
immunology (and likely nearly every organ system and scientific discipline) mean that
almost nothing is ever absolute and that there is nearly always an exception to the rule.
This makes generalizations difficult and communicating these complexities to the
layperson even harder. When about 30% of Americans have low scientific literacy, one
may contemplate whether it is more important to convey the overall meaning, or to focus
on the process1? For rapid dissemination of information, the former is preferred, but to
increase scientific understanding, the process of science is vital2.
Ecologists have had the uphill battle of educating the public for decades about the
disasters of climate change3, but the extent of scientific misinformation and
disinformation being relayed to the layperson has now extended to biomedical sciences
(beyond the ongoing anti-vaccine movement4). When government agencies also fail at
communicating (the Center for Disease Control and Prevention never achieved above
45% approval for their clarity on pandemic plans5), an open void is left for
misinformation. The World Health Organization has declared an “infodemic” regarding
the magnitude of dangerous and misleading COVID-19 information6, and the
Proceedings of National Academy of Sciences recently published a special issue on the
topic7 in which the problem is formally addressed, the data are analyzed, and solutions
are proposed2, 8-14. Unfortunately, there is no singular solution to the issue, as the
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influence of digital media, political ideologies, and socioeconomic factors that limit the
reach of information15 make this a multifaceted societal issue that is not investigated in
this dissertation.
While digital media and social media can be partially blamed for the influx of
science-disbelievers and spread of misinformation16-18, these forms of communication
have some positive aspects. The real-time dissemination of scientific data during the
COVID-19 pandemic led to rapid mobilization of collaborative efforts19. For example,
the SARS-CoV-2 genome was first posted on January 10th, 2020. By January 12th, there
was a comparison of several viral genomes, and on the 15th a RT-qPCR primer set had
been developed, tested, and posted. This speed outpaces preprints, but the same caution
for accuracy has been advised19.
Social media can also provide a stage for scientists to educate general audiences.
In conjunction with the Larner College of Medicine, I produced two videos on PCR- and
ELISA-based COVID-19 testing (links provided in Figure 1). These were an early
attempt to demystify the testing that became a vital resource to continue the research
within this dissertation. The videos were designed to target individuals with a basic
understanding of life sciences and provided an exercise in communication. While
animations like these would help scientists explain their own research to a lay audience,
they are cost and time prohibitive. The price of a custom animation begins at a few
thousand dollars and can take dozens of hours that may be better spent in the lab. While
there is ample enthusiasm for scientific communication, the practice remains difficult and
resource intensive.
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Figure 1 COVID-19 Testing Videos. The QR codes above will direct the reader to
videos created for the Larner College of Medicine. A) PCR testing. This video explains
the basic concepts behind PCR based screens and was created using Microsoft
Powerpoint and Adobe Premier Pro. B) Serological Testing. The more intricacies of
antibody binding and detection of antibodies using ELISA required the use of Adobe
Premier Pro and Adobe After Effects.

5.4 Skeletal muscle and mRNA
The COVID-19 pandemic has brought mRNA therapeutics into the main stage,
with over 4.35∙108 does of Pfizer’s Comirnaty and Moderna’s Spikevax administered in
the US by December 202120. This technology began development over 40 years ago, with
the first liposome encapsulated mRNA experiments published in 197821, 22. However, the
technology needed substantial refinement, and two breakthroughs allowed for enhanced
efficacy of mRNA-based technology. First, the use of modified nucleosides meant that
engineered mRNA could avoid activating TLR3, TLR7, and TLR823. Activation of these
TLRs and subsequent antiviral responses can effectively shut down translation within the
cell24, 25 and induce apoptosis26. The second breakthrough came in the form of the
delivery vehicle. While liposome-mediated nucleic acid delivery has been used
extensively in research settings and cell culture work for small interfering RNA27, 28, the
inclusion of an ionizable lipid and the ability to form nanoparticles allowed for longer
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stability, degradation escape, and enhanced delivery29. When these two modifications are
combined, as is the case in Comirnaty and Spikevax, the target mRNA can be effectively
translated into antigen and induce a potent immune response.
The intersection between mRNA vaccine technology and this dissertation meets at
the deltoid. Skeletal muscle injections have been the preferred route of vaccination due to
the ease of access and the limitation of adverse events. Subcutaneous vaccines provide
similar protective immunity as intramuscular; however, skin irritation at the injection site
is a less desirable outcome than myalgia30. As we have seen in Chapters 2 and 3, muscle
can be potently immunogenic, and crosstalk between the innate immune system and
myocytes is common. Exercise has already been proposed as an adjuvant in several
vaccinations, including those for influenza31, tetanus32, pneumococcus33, and
meningococcus34, with evidence of mixed results. These trials were performed using
traditional vaccines – that is, either subunit or live/attenuated vaccine platforms - and rely
on using exercise to damage the muscle (attracting leukocytes) and to stimulate lymphatic
circulation (return them to draining lymph nodes)35. What we have proposed in Appendix
B is vastly different.
Exercise, particularly hypertrophic movements, augments the mammalian target
of rapamycin (mTOR) pathway and antagonizes AMPK-based growth inhibition36-38. We
have proposed commandeering this phenomenon by using appropriately timed exercise or
mTOR pharmacological activation to boost the amount of protein produced by an mRNA
based therapeutic (Appendix B). We carefully use the word therapeutic and not vaccine
in this scenario because antigen abundance is not directly tied to enhanced protective
immunity, and different cellular responses require different quantities. This theory may
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be better suited for mRNA that encodes antibodies, or to replace an absent protein. We
have currently begun in vitro experiments to investigate if modulating mTOR activation
in skeletal muscle myotubes leads to altered protein production, as are described in the
following paragraph.
To repurpose skeletal muscle as a protein translation machine, we transcribed
mRNA encoding enhanced green fluorescent protein (eGFP) or a modified version of the
Pfizer Comirnaty and administered it to C2C12 myotubes in combination with the mTOR
inactivation molecules rapamycin and resveratrol, or activated the mTOR pathway by
combining mRNA with insulin-like growth factor 1 (IGF-1). We hypothesized that the
small molecules would decrease the production of our mRNA-encoded protein, and that
stimulation with IGF-1 would enhance protein synthesis of exogenous mRNA. Our
preliminary results support this hypothesis, with significant decreases in eGFP
fluorescence in the presence of rapamycin and resveratrol and significant increases in
myotubes that received IGF-1 (Figure 2 A-C). For relevant application to the mRNA
vaccines being produced as of the writing of this dissertation, we administered a modified
Comirnaty mRNA to C2C12 myotubes (Figure 2D) and measured significant increases in
the production of the FLAG-tagged Spike protein.
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Figure 2 Augmenting protein translation of exogenous mRNA in C2C12 myotubes.
Inhibition of mTOR using rapamycin (A) and resveratrol (B) decreases exogenous
mRNA translation of eGFP as measured by fluorescence. The addition of IGF-1, which is
upstream of activating mTOR, increases the fluorescence of eGFP as well as protein
translation of the Pfizer Comirnaty vaccine. In these experiments, in vitro transcribed
mRNA was delivered using Mirus TransIT mRNA reagent. The Comirnaty sequence was
modified by adding a T7 RNA polymerase promoter to the 5’ UTR, and an insertion was
made to encode for a FLAG peptide on the N-terminus. A) Two-way ANOVA with
Tukey’s multiple comparisons B) unpaired t test C) one-way ANOVA with Dunnett’s
multiple comparisons D) unpaired t test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
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Further research is required to determine if exercise or in vitro muscle contraction
can elicit similar results. To determine this in vitro, we will use an electrical stimulation
device to force C2C12 myotubes to contract within their cell culture plates. As we
continue our studies and move to in vivo modeling, the LOST-Wheel will be incorporated
to appropriately time and limit exercise in mice receiving intramuscular injections of our
exogenous mRNA. Our work determining skeletal muscle cytokine secretion will also be
helpful to establish whether exercise enhances or attenuates mRNA therapeutic elicited
cytokine secretion.

5.5 Final remarks
The road to this dissertation was not a direct path, and many detours were taken to
write the document you are reading now. However, each bump and setback became an
opportunity for a comeback. Our work with cytokine secretion had been published not
once, but twice, as our mice were breeding39, 40, and global pandemic and supply chain
issues did not make the process any easier. However, these obstacles allowed me to pivot
and pursue endeavors that may not have been otherwise investigated (animation, LOSTWheel, mRNA technology). The final implication of this dissertation is that it has set up
the skills necessary to rapidly experiment, prototype, and communicate science in the
modern world.
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APPENDIX A: ADIPOCYTE AND MYOTUBE COCULTURE

Objective: To determine if skeletal muscle myocytes and intramuscular adipose tissue
(IMAT) interact at similar capacity as C2C12 myotubes and bone marrow derived
macropahges (BMDM).
Rationale: In healthy human muscle, IMAT occupies approximately 5% of the crosssectional area. In obese human muscle this content can accumulate to 15% or more of the
muscle’s volume. Since adipocytes potently secrete pro-inflammatory cytokines, we
investigated the ability for these two tissues to interact after lipopolysaccharide (LPS)
stimulation.
Methods: C2C12 myotubes were differentiated as previously described [1]. On day 7 of
C2C12 differentiation, 3T3-L1 adipocytes (INSERT CITATION) were added to the
myotubes at concentrations that were equivalent to 5% and 15% of the well surface area.
After overnight acclimation, cells were treated with 1 ug/ml LPS for 4 and 24 hours. 4
hour cells were analyzed for gene expression of Il6, Ccl2, Cxcl1, and Tnf using RTqPCR. 24 hour supernatants were analyzed for the respective proteins using ELISA.
Results: A-D Gene expression of proinflammatory cytokines. E-G Supernatant cytokine
concentration.
Conclusion: While LPS increased proinflammatory gene expression and secretion in
individual and coculture conditions, there were no synergistic increases in cocultures
compared to monoculture conditions treated with LPS. The percent of IMAT did not
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yield any discernable pattern among cytokine secretion and expression, suggesting that
these cell types do not interact in this context.
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APPENDIX B: EXPLOITING EXERCISE ENHANCED PROTEIN SYNTHESIS TO
AUGMENT MRNA VACCINE TRANSLATION
SPECIFIC AIMS
Caused by the SARS-CoV-2 virus, COVID-19 has impacted every aspect of the
global population during the previous year by infecting the respiratory system and
frequently manifesting the need for critical care for the most severely-affected patients. In
an incredible accomplishment of biomedical science, two effective vaccines against
SARS-CoV-2 were developed, tested, and distributed in 2020. In an equally impressive
act of logistics and public health policy, the United States aims to vaccinate 100 million
people by May 2021 (1). Using a novel mRNA-based platform, a new vaccination
strategy has emerged to combat this disease that is distinct from traditional methods.
While the excitement of this achievement is well deserved, this new platform requires
rigorous study for ways in which to improve upon it, or to identify factors that decrease
the efficiency of developing protective immunity.
The mRNA vaccine platform can be envisioned as a large-scale transfection.
Lipid nanoparticles (LNPs) containing modified mRNA need to efficiently enter cells,
avoid degradation, and be translated into functional SARS-CoV-2 spike proteins (S
proteins) (2-4). The intramuscular administration of the vaccine provides a large protein
factory in the form of skeletal muscle to create ample antigen necessary for the
subsequent immune response. Historically, primary muscle has been difficult to transfect,
with maximal in vitro efficiency around 50% using commercially available lipid-based
transfection reagents (5, 6). While the SARS-CoV-2 mRNA vaccines use a lipid-based
formulation, the proprietary nanoparticles may increase efficiency through a myriad of
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proposed mechanisms (7). A key development to increasing transfection, and ultimately
protective immunity of these vaccines, will be to understand how muscle contraction
(mediated by exercise) changes transfection efficiency and production of the exogenous
protein.
Exercise induces a variety of changes in skeletal muscle. Some are immunogenic,
with increased cytokine and chemokine production leading to recruitment of innate
immune cells (8-10). Other changes are due to the mechanical stress of contraction that
induces tissue and cellular damage (11). Exercise regimens differ in their ability to induce
these changes. Eccentric contraction is well characterized as the most damaging form
(12), whereas concentric contraction increases muscle protein synthesis by 50% and
109% at 4 and 24 hours, respectively (13). Our proposed studies will investigate the
effect of exercise on exogenous mRNA translation. We hypothesize that appropriately
timed concentric exercise will increase LNP-delivered mRNA translation through
increased muscle protein synthesis. This augmentation of exogenous protein synthesis
will increase antigen presentation and elicit more robust antibody production than in
sedentary controls. We will first determine the temporal kinetics of in vivo LNP-mRNA
muscle transfection. Using these data, we will evaluate if concentric exercise
administered prior to maximal exogenous protein production can enhance translation. We
will also interrogate the damaging effect of eccentric exercise to determine if myofiber
disruptions attenuate exogenous protein synthesis. Our studies will conclude with assays
to determine antibody abundance with future plans to determine functional neutralization
of virions in exercised animals.
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Aim 1: Determine the temporal kinetics of mRNA vaccine translation and
cytokine response to lipid nanoparticles. Using in vivo live animal imaging and an
mRNA vaccine encoding for tDtomato fluorescent protein, we will determine
transfection lag time and maximal translation of LNP-delivered mRNA. We have
previously determined that transfection of mRNA induces translation in vitro using fully
differentiated C2C12 myotubes expressing exogenous GFP and will compare isolated
myocyte kinetics to the heterogenous cellular population of muscle tissue. We will also
assess the immunomodulatory activity of the LNP-mRNA by RNAseq.
Aim 2: Examine the effect of exercise enhanced protein synthesis from
exogenous mRNA. In this aim we will administer concentric exercise to mice, or
electrical stimulation to C2C12 myotubes, prior to maximal mRNA vaccine translation to
augment synthesis. We will track GFP production in vitro and measure SARS-CoV-2
spike protein in vivo to determine if exercise augments antigen production. These
experiments will be repeated, and mice will be allowed to generate antibodies for 10 days
to determine if increased spike protein leads to increases in circulating antibodies.
Additionally, muscle and lymph nodes draining the injection site will be analyzed for
infiltrating leukocytes, muscle antigen presentation, and antigen presentation in the
lymph node. Finally, we will activate a protein synthesis pathway upon vaccine delivery
using upstream mediators and small molecule activators of mTOR to determine if the
exercise induced enhancement can be replicated through a pharmacological approach.
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RESEARCH STRATEGY
Although a component of a larger vision to elicit more functional immunoprotective
vaccine responses against SARS-CoV-2 and other LPN-mRNA vaccinations, for the
purposes of this VLC Pilot Project proposal, we will focus our efforts on two important
aspects of this project, with the intention of generating the necessary, compelling
preliminary data to substantiate an R01-level extramural application to conduct additional
immunological and viral-neutralization studies.
The results of our studies will provide insight on the fundamental contribution of muscle
to mRNA vaccine-mediated protective immunity. The success of the SARS-CoV-2
vaccine will undoubtably revolutionize future pandemic and perhaps seasonal vaccines.
We envision these data will be used to make informed guidelines on human activities
preceding immunization.
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Significance
At the time of this submission, the United States has surpassed 25 million cases and 417
thousand deaths from COVID-19 (14). Additionally, 110,000 individuals are hospitalized
across the country (15). With over 7,100 patients (27 states reporting) currently on
mechanical ventilation, these morbid statistics remind us of the fragility of the lungs to
respiratory viruses (16). Patients with COVID-19 will be affected for much longer than
the virus remains in their system, as recovery from COVID-19 is a lengthy process (17)
and can lead to a chronic lung condition akin to COPD. We must also recognize the
thrombotic effects of the virus leading to stroke and pulmonary embolism (18-20).
Finally, as the pandemic has drawn on, extended symptoms, named long COVID, have
appeared that will be investigated by the PHOSP-COVID and C4R studies (21).
While the aforementioned studies will investigate the future, today’s unfortunate truth of
the pandemic is that vaccine manufacturing and distribution are woefully lagging behind
the demand needed to protect communities in the United States. At the current rate of
vaccinations, the critical and debated 70% needed for herd immunity will not be reached
until October, 2021 (22). The two-injection schedule of both Moderna and
Pfizer/BioNTech vaccines poses an additional supply chain bottleneck and potential for
delays between doses. A recent report from Israel differs from Pfizer/BioNTech clinical
data, with the first injection only providing 33% protection instead of 52%, respectively
(23, 24). Yet, what if there was a way to improve vaccine efficacy after the first injection
and could this be done in a non-invasive, safe, and easily implemented manner? By
exploiting muscle protein synthesis, we plan assess the potential of using exercise to
answer this question.

163

Innovation
The experiments proposed in this application work with technologies only recently
approved for human use. mRNA vaccines will expand beyond infectious diseases and are
being developed for cancer and autoimmune disease (25-27). Due to the novelty of this
platform, it is imperative to understand factors that augment or attenuate efficacy. This
pilot grant will allow our group to establish a LNP formulation and in vitro techniques
that can be applicable across multiple disciplines. Our group has a strong history of
collaboration across departments and disciplines and can provide insight and equipment
for future joint endeavors.
We have also begun prototyping a new device for murine exercise. We have
considered alternative approaches of exercise such as forced treadmill running, but the
adverse “motivational” shock events from treadmills and handling induces stress that will
confound results (28, 29). While unregulated voluntary wheel running may be an
alternative, mice will run up to 20 km a day and for up to 7 hours, which we do not
believe to be an accurate representation of the average human. Our prototype can be
programmed to lock and prevent movement after reaching time or distance milestones,
limiting the exercise to more physiological conditions. Weighted wheel running is known
to induce hypertrophic changes in muscle (30, 31), so our next iteration will employ
adjustable electromagnetic resistance.
Finally, we propose using the small molecule, 3BDO, as a modulator of mTOR
(mTORC1) activity to increase exogenous mRNA translation. This molecule was only
recently discovered to increase mTOR activity and could be a potential therapeutic
administered in formulations of future vaccines (32).
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Aim 1: Determine the temporal kinetics of mRNA vaccine translation and cytokine
response to lipid nanoparticles.
Background
Intramuscular injections have been proven to be safe, efficacious, and easily
administered routes of vaccination (33, 34). While traditional vaccines rely on preformed
recombinant proteins, live attenuated virus, or pathogen homogenates, the newly
developed mRNA vaccines are fundamentally different, requiring the cells within muscle
to manufacture the exogenous protein. Following translation and required to induce full
protective immunity, the viral protein encoded in the SARS-CoV-2 vaccine mRNA must
be recognized by antigen presenting cells, phagocytosed, and presented to leukocytes
within the draining lymph node. Since the deltoid is the chosen site of COVID-19
vaccines, and myocytes/myofibers constitute the majority of cells within the tissue, it is
logical that exogenous vaccine mRNA will be translated by muscle as the critical first
step in generating protective immunity.
Pre-clinical studies by both Moderna and Pfizer/BioNTech loosely determined the
kinetics of mRNA translation (7, 35, 36). Moderna’s study used a model of intravenous
injection instead of intramuscular. While a time course for LNP localization and
quantification was performed, an assay for translated protein was not (7). Instead,
intravenous injections were administered and the transfection efficiency of different lipid
formulations was measured at 6 hours (35). Pfizer/BioNTech performed more rigorous
testing on their LNP formulation using an in vitro time course in HEK293T and human
dendritic cells (36). Their kinetic study showed maximal protein expression at 24h. Yet
these conditions are far from an intramuscular injection and did not determine at which
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point the decrease in translation occurred. Another experiment, however, measured
intramuscular luciferase translation and found peak luminescence of LNP-delivered
mRNA at 4 hours and a half-life of intramuscular exogenous mRNA of around 20.6
hours (36). Total protein was measured, but an omission of units in the publication leaves
these data open to interpretation (36). Neither study attempted to identify which cell types
are responsible for protein translation nor the initial cytokine response to foreign mRNA.
The implementation of this new vaccine platform requires unbiased, rigorous
examination. We propose to address the pitfalls of the aforementioned studies, as well as
investigate the kinetics of mRNA induced exogenous protein production and endogenous
cytokine profile following injection with mRNA-LNP. We hypothesize that maximal
translation of exogenous protein by myocytes will occur prior to 20 hours and will be
accompanied by active expression and secretion of immunomodulatory cytokines. Our
preliminary data using C2C12 mouse myotubes have shown that isolated muscle cells
reach maximal translation of exogenous mRNA at 16 hours, preceding that reported in
HEK-293 cells and from in vivo studies performed by Pfizer/BioNTech (Figure 1). We
have assessed several common proinflammatory cytokines via qPCR and found Il6, Tnf,
Ccl2, and Cxcl1 were all significantly elevated at 24 hours (Figure 1). These preliminary
data were performed with unmodified mRNA, and a lipid-based delivery vehicle
differing from SARS-CoV-2 vaccine formulations. Future experiments will substitute
uracil for pseudouridine in the mRNA to reduce immunogenicity and match the base
modifications used in commercial vaccines. We will also enhance the lipid formulation to
create nanoparticles to be conjugated with the modified mRNA. This formulation consists
of an ionizable amino lipid (heptatriaconta-6,9,28,31-tetraen-19-yl 4-
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(dimethylamino)butanoate, DLin-MC3-DMA), phosphatidylcholine (1,2-dioleoyl-snglycero-3-phosphocholine, DOPC), cholesterol, and a coat lipid (polyethylene glycoldimyristolglycerol, PEG-DMG) at molar ratio of 50:10:38.5:1.5. They will be assembled
using a microfluidic mixer with the help of Dr. Dev Majumdar (letter of support attached)
and evaluated for quantity and size distribution using the NanoSight Microparticle
Counter within UVM’s Henry Basset Flow Cytometry Facility.
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Approach
Aim 1.1: Assess in vivo translation kinetics of exogenous mRNA delivered
intramuscularly by LNP. Using LNP encapsulated mRNA encoding the red fluorescent
protein tDtomato (see letter of support from Dr. Majumdar, a UVM expert in the novel
mRNA-LNP vaccine platform), we will perform time course experiments in C57BL/6
hairless, albino mice (Jackson Labs Strain 017840). LNP-tDtomato or LNP-scramble
solutions will be injected intramuscularly as a 50 µl single-shot bolus into the
gastronemius muscle, as we have done for TNF injections in our manuscript under
review. Beginning 1 hour after injection and until as much as 1 week after, mice will be
anesthetized with inhaled isoflurane and imaged using the IVIS II live animal imager in
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the UVM Microscopy imaging center. This will enable both qualitative and quantitiative
assessment of reporter protein production. We will focus on the injected muscle as well
as on extra-muscular sites (e.g., liver) in which injected LNP-mRNA-derived proteins
may be produced. Multiple groups will be used to monitor translation hourly without
prolonged sedation.
Aim 1.2: Confirm muscle translation of exogenous mRNA. Mice will receive
intramuscular injections of LNP-tDtomato formulations and euthanized for study at a
timepoint determined to confer maximal exogenous mRNA translation by Aim 1.1.
Muscle tissue from the injection site will be ebbedded in OCT, frozen, sectioned, and
imaged via fluorescent microscopy to identify foci of exogenous mRNA translation.
Immunostaining and hematoxylin/eosin staining of adjacent sections will be used to
identify particular resident and inflammatory cell types in the muscle tissue. We predict
myofibers will constitute the vast majority of translation with minimal translation from
resident leukocytes, fibroblasts, and satellite cells.
Aim 1.3: Perform an unbiased investigation of transcriptional changes
caused by LNP-mRNA. The immunogenicity of LNP formulations in muscle alone has
not yet been determined. We have previously shown that muscle rapidly responds to
pathogen associated molecular patterns with upregulation of Il6, Tnf, Ccl2, and Cxcl1
within 3 hours of intramuscular injection and within 2 hours after the addition of LPS to
myotube cultures (awaiting editorial decision, The FASEB Journal, Feb 2, 2021). We
predict that a similarly rapid increase in the expression of these cytokines and many
additional genes will also occur following LNP-mRNA treatment. We will subject
C2C12 mouse skeletal muscle myotubes (purchased from ATCC and maintained
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according to protocols routinely employed in our laboratory) to treatment with both LNPmRNA formulations, as well as traditional adjuvants (e.g., Alum, Freund’s Complete,
MF59) and collect lysate for RNA-sequencing to be performed by the Vermont
Integrative Genomics Resource. Because cytokine secretion followed by leukocyte
infiltration is required for protective immunity, we will compare the vaccination
platforms. Identification of specific mRNA changes and validation of candidate proteins
will be utilized in Aim 2, and will also provide potentially valuable targets for future
study.

Aim 2: Examine the effect of exercise enhanced protein synthesis from exogenous
mRNA.
Background
The notion that exercise may produce adjuvant-like effects during intramuscular
vaccinations is not a novel concept and it has been hypothesized that acute stress
mediates immunoenhancement (37). Rodent models have provided support for the acute
stress hypothesis, with reports of exercise and restraint stress augmenting antigen
response (38-40). Seminal literature in humans would argue against this enhancement, as
the open window hypothesis suggests immunosuppression following exhaustive exercise
(41). However, these studies have also been vigorously refuted (42). In humans,
enhanced responses have been shown using eccentric exercise timed in accordance with
muscle damage and peak cytokine levels (43). Yet similarly timed vaccination-exercise
regimens in subsequent studies showed no differences among groups (44). These studies
attempted to use injection site-adjacent muscle damage to drive leukocyte infiltration. On
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a global-body scale, cycling-vaccine intervention exercise increases response to weakly
immunogenic antigens, further promoting the adjuvant effect of exercise (45, 46).
Literature may show a trend toward this hypothesis, but these trials were performed using
the last generation of vaccines. In the coming years, mRNA vaccines will cover not only
infectious diseases, but also cancer, autoimmune, and possibly allergic diseases. While
the acute stress hypothesis may continue to hold true in these novel platforms, a second
mechanism may also prevail. Therefore, we plan to investigate exercise augmented
protein synthesis as a potential mechanism of mRNA vaccine enhancement.
The plasticity of muscle allows for adaptations to exercise. Concentric
(shortening) contractions have been well documented in both humans and animal models
to increase endogenous protein synthesis over 24 hours (13, 47). This increase occurs in
both untrained and trained individuals (48). These types of exercise regimens are
commonly and easily implemented in humans as they entail mostly running and
resistance training movements. Summarized in (49), resistance exercise can increase prerRNA synthesis in as little as 4 hours and can also be detected up to 24 hours following
completion. We hypothesize a critical period exists during which exogenous protein
translation can be increased by concentric exercise. Exercise induces protein synthesis
through activation of mTOR signaling pathways. This rheostat for cellular metabolism
may be a potential pharmacological target for individuals unable to perform therapeutic
exercise. Finally, in addition to increasing protein synthesis, exercise may help deliver
cells necessary to generate protective immunity to the site of injection. Dendritic cells,
which facilitate antigen presentation, increase in abundance following both resistance and
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aerobic exercise (50, 51). This mechanism can potentially connect our hypothesis with
the acute stress ideology.
Approach
Aim 2.1 – Determine the effect of exercise on LNP-mRNA translation and
modification of immunomodulatory cytokines. This subaim will use both in vitro and
in vivo approaches to exploit increases in myocyte protein translation following exercise
to enhance exogenous protein production. In our in vitro approach (see letter of support
from Dr. Toth, a UVM expert in exercise physiology and myocyte biology), we will
electrically stimulate C2C12 myotubes for one hour (20 V, 1 Hz, 12 ms) to mimic an
exercise protocol (52). At 4, 8, and 24 hours, myotubes will be treated with LNP-Gfp.
Following an additional 24 hour incubation with the exogenous mRNA, myotubes will be
analyzed for GFP fluorescence and production of cytokines and expression of genes
identified in Aim 1.3. In vivo experiments will employ a novel exercise wheel that has
been designed and prototyped in our laboratory to limit murine exercise to timetables
appropriate to human lifestyles (Figure 2). Exercise will be limited to 2 hours and
followed by a single injection with LNP-SARS-CoV-2 S protein mRNA (LNP-Spike) at
4, 8, and 24 hours following termination of exercise. At a time determined from Aim 1.2,
mice will be euthanized and both injected muscle and draining inguinal lymph nodes will
be excised for analysis of S protein and cytokine content by RT-qPCR and commerciallyavailable immunoassays. We will then repeat this experiment at the optimal time of
injection and allow mice to generate protective antibodies for 10 days, at which point we
will determine the effect of exercise on antibody generation using commercially-available
ELISAs that enable quantification of mouse antibodies recognizing the spike protein.
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Aim 2.2 – Quantify skeletal muscle leukocyte infiltration following exercise
and LNP-mRNA. To determine if exercise modifies the LNP-mRNA mediated
infiltration of leukocytes needed to initiate protective immunity, mice will be subjected to
limited exercise followed by injection of LNP-Spike at a time optimized for maximal
exercise enhanced protein production from Aim 2.1. After 48h, muscle and draining
inguinal lymph nodes will be dissociated through physical and enzymatic digestion using
a Miltenyi GentleMACS into single cell suspensions and immunostained using
commercially-available antibodies already in the laboratory for flow cytometric analysis.
Dendritic cells will be quantified to determine if exercise imparts additional chemotactic
properties to the site of injection for these important innate-immune-bridging cells.
Additionally, dissociated muscle will be stained for markers of macrophages and
neutrophils to investigate the potentially pro-inflammatory nature of LNP-mRNA
vaccines to attract these innate leukocytes. Some samples will be sectioned and analyzed
through immunohistochemistry for antigen presentation on muscle fibers and to confirm
flow cytometry data.
Aim 2.3 – Investigation of a pharmacological alternative to increasing
protein translation. As an alternative to exercise, insulin-like growth factor 1 (IGF-1,
protein) and 3-benzyl-5-((2-nitrophenoxy) methyl)-dihydrofuran-2(3H)-one (3BDO,
small molecule) will be combined with LNP-Gfp for in vitro proof of concept studies
using the C2C12 myotube system, or LNP-Spike intramuscular injections into C57BL/6
(in some instances albino for IVIS live animal imaging) to investigate whether the
activating upstream regulators of mTOR or the protein itself will increase exogenous
protein translation. In an alternative approach, we will inhibit the AMPK pathway, which
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antagonizes mTORC1 using Compound C (dorsomorphin) (53), first in vitro as a proof of
principle.

Statistical Analysis, Rigor, and Reproducibility
In vitro experiments will be conducted using biological quadruplicates and studies
will be completed three times. In vivo studies will be conducted using n = 6 mice/group
based on prior investigator experience, but refined using power analyses conducted on
preliminary studies. Benchtop assays will be conducted using technical duplicates. Data

will be analyzed by one- or two-way ANOVA and appropriate post-hoc tests will be
conducted for multiple comparisons. A p value smaller than 0.05 will be considered
statistically significant. The UVM College of Medicine Biostatistics Unit will be
consulted for final statistical analyses.
Anticipated Results and Future Directions
The studies proposed in this grant will provide important preliminary data to
guide the completion and submission of R01 or R21 proposals. Larger proposals will
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include determining if exercise alters antibody functionality, further interrogation the
mode of exercise on exogenous mRNA translation, and if our observed effects hold true
in geriatric models.
While we will collect serum from vaccinated mice 10 days following vaccination
± exercise, we only plan to quantify antibody quantity, but the quality of these proteins
should not be overlooked. We propose that exercise may increase protective immunity
after only one vaccination, so at the completion of these studies we will look to assess
neutralization capacity using infectious SARS-CoV-2 virions.
Although our in vivo studies are focused on concentric exercise, we could in future
studies also interrogate the damaging effect of eccentric exercise to determine if myofiber
disruptions attenuate exogenous protein synthesis. Eccentric exercise may inhibit
translation due to the damage it induces in muscle. Yet this damage may recruit
additional leukocytes to the muscle and cancel the reduced production. Eccentric exercise
experiments require sophisticated equipment and personnel training to electrically
stimulate in vivo muscle and are outside the scope of this grant mechanism.
Timeline
Aim 1 will begin immediately, with Aim 2 beginning shortly thereafter informed
by results from the first aim.
IACUC
The research proposed in this VLC Pilot Project has been approved by UVM
IACUC - PROTO202100027
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